|
Drug Target 1
[top]
|
| Target 1 ID |
291 |
| Target 1 Name |
Nitric-oxide synthase, endothelial |
| Target 1 Synonyms |
- Constitutive NOS
- EC 1.14.13.39
- EC-NOS
- Endothelial NOS
- NOS type III
- NOSIII
- cNOS
- eNOS
|
| Target 1 Gene Name |
NOS3 |
| Target 1 Protein Sequence |
>Nitric-oxide synthase, endothelial
GNLKSVAQEPGPPCGLGLGLGLGLCGKQGPATPAPEPSRAPASLLPPAPEHSPPSSPLTQ
PPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPE
QLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNA
PRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDF
RIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPE
LFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTE
IGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHH
AATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPWK
GSAAKGTGITRKKTFKEVANAVKISASLMGTVMAKRVKATILYGSETGRAQSYAQQLGRL
FRKAFDPRVLCMDEYDVVSLEHETLVLVVTSTFGNGDPPENGESFAAALMEMSGPYNSSP
RPEQHKSYKIRFNSISCSDPLVSSWRRKRKESSNTDSAGALGTLRFCVFGLGSRAYPHFC
AFARAVDTRLEELGGERLLQLGQGDELCGQEEAFRGWAQAAFQAACETFCVGEDAKAAAR
DIFSPKRSWKRQRYRLSAQAEGLQLLPGLIHVHRRKMFQATIRSVENLQSSKSTRATILV
RLDTGGQEGLQYQPGDHIGVCPPNRPGLVEALLSRVEDPPAPTEPVAVEQLEKGSPGGPP
PGWVRDPRLPPCTLRQALTFFLDITSPPSPQLLRLLSTLAEEPREQQELEALSQDPRRYE
EWKWFRCPTLLEVLEQFPSVALPAPLLLTQLPLLQPRYYSVSSAPSTHPGEIHLTVAVLA
YRTQDGLGPLHYGVCSTWLSQLKPGDPVPCFIRGAPSFRLPPDPSLPCILVGPGTGIAPF
RGFWQERLHDIESKGLQPTPMTLVFGCRCSQLDHLYRDEVQNAQQRGVFGRVLTAFSREP
DNPKTYVQDILRTELAAEVHRVLCLERGHMFVCGDVTMATNVLQTVQRILATEGDMELDE
AGDVIGVLRDQQRYHEDIFGLTLRTQEVTSRIRTQSFSLQERQLRGAVPWAFDPPGSDTN
SP
|
| Target 1 Number of Residues |
1222 |
| Target 1 Molecular Weight |
133159 |
| Target 1 Theoretical pI |
7.27 |
| Target 1 GO Classification |
|
Function
|
cofactor binding
coenzyme binding
NADP binding
purine nucleotide binding
adenyl nucleotide binding
FAD binding
tetrapyrrole binding
heme binding
protein binding
calmodulin binding
ion binding
cation binding
transition metal ion binding
iron ion binding
monooxygenase activity
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD or NADH as one donor, and incorporation of one atom of oxygen
nitric-oxide synthase activity
binding
nucleotide binding
FMN binding
transporter activity
electron transporter activity
catalytic activity
oxidoreductase activity |
|
Process
|
biosynthesis
nitric oxide biosynthesis
physiological process
metabolism
cellular metabolism
generation of precursor metabolites and energy
electron transport |
|
Component
|
| Not Available |
|
| Target 1 General Function |
Inorganic ion transport and metabolism |
| Target 1 Specific Function |
Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. No mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets |
| Target 1 Pathways |
|
| Target 1 Reactions |
- L-arginine + n NADPH + n H+ + m O2 = citrulline + nitric oxide + n NADP+
|
| Target 1 Pfam Domain Function |
|
| Target 1 Signals |
|
| Target 1 Transmembrane Regions |
|
| Target 1 Essentiality |
Non-Essential |
| Target 1 GenBank ID Protein |
189212  |
| Target 1 UniProtKB/Swiss-Prot ID |
P29474  |
| Target 1 UniProtKB/Swiss-Prot Entry Name |
NOS3_HUMAN  |
| Target 1 PDB ID |
3NOS  |
| Target 1 PDB File |
Show |
| Target 1 3D Structure |
|
| Target 1 Cellular Location |
Not Available |
| Target 1 Gene Sequence |
>3612 bp
ATGGGCAACTTGAAGAGCGTGGCCCAGGAGCCTGGGCCACCCTGCGGCCTGGGGCTGGGG
CTGGGCCTTGGGCTGTGCGGCAAGCAGGGCCCAGCCACCCCGGCCCCTGAGCCCAGCCGG
GCCCCAGCATCCCTACTCCCACCAGCGCCAGAACACAGCCCCCCGAGCTCCCCGCTAACC
CAGCCCCCAGAGGGGCCCAAGTTCCCTCGTGTGAAGAACTGGGAGGTGGGGAGCATCACC
TATGACACCCTCAGCGCCCAGGCGCAGCAGGATGGGCCCTGCACCCCAAGACGCTGCCTG
GGCTCCCTGGTATTTCCACGGAAACTACAGGGCCGGCCCTCCCCCGGCCCCCCGGCCCCT
GAGCAGCTGCTGAGTCAGGCCCGGGACTTCATCAACCAGTACTACAGCTCCATTAAGAGG
AGCGGCTCCCAGGCCCACGAACAGCGGCTTCAAGAGGTGGAAGCCGAGGTGGCAGCCACA
GGCACCTACCAGCTTAGGGAGAGCGAGCTGGTGTTCGGGGCTAAGCAGGCCTGGCGCAAC
GCTCCCCGCTGCGTGGGCCGGATCCAGTGGGGGAAGCTGCAGGTGTTCGATGCCCGGGAC
TGCAGGTCTGCACAGGAAATGTTCACCTACATCTGCAACCACATCAAGTATGCCACCAAC
CGGGGCAACCTTCGCTCGGCCATCACAGTGTTCCCGCAGCGCTGCCCTGGCCGAGGAGAC
TTCCGAATCTGGAACAGCCAGCTGGTGCGCTACGCGGGCTACCGGCAGCAGGACGGCTCT
GTGCGGGGGGACCCAGCCAACGTGGAGATCACCGAGCTCTGCATTCAGCACGGCTGGACC
CCAGGAAACGGTCGCTTCGACGTGCTGCCCCTGCTGCTGCAGGCCCCAGATGAGCCCCCA
GAACTCTTCCTTCTGCCCCCCGAGCTGGTCCTTGAGGTGCCCCTGGAGCACCCCACGCTG
GAGTGGTTTGCAGCCCTGGGCCTGCGCTGGTACGCCCTCCCGGCAGTGTCCAACATGCTG
CTGGAAATTGGGGGCCTGGAGTTCCCCGCAGCCCCCTTCAGTGGCTGGTACATGAGCACT
GAGATCGGCACGAGGAACCTGTGTGACCCTCACCGCTACAACATCCTGGAGGATGTGGCT
GTCTGCATGGACCTGGATACCCGGACCACCTCGTCCCTGTGGAAAGACAAGGCAGCAGTG
GAAATCAACGTGGCCGTGCTGCACAGTTACCAGCTAGCCAAAGTCACCATCGTGGACCAC
CACGCCGCCACGGCCTCTTTCATGAAGCACCTGGAGAATGAGCAGAAGGCCAGGGGGGGC
TGCCCTGCAGACTGGGCCTGGATCGTGCCCCCCATCTCGGGCAGCCTCACTCCTGTTTTC
CATCAGGAGATGGTCAACTATTTCCTGTCCCCGGCCTTCCGCTACCAGCCAGACCCCTGG
AAGGGGAGTGCCGCCAAGGGCACCGGCATCACCAGGAAGAAGACCTTTAAAGAAGTGGCC
AACGCCGTGAAGATCTCCGCCTCGCTCATGGGCACGGTGATGGCGAAGCGAGTGAAGGCG
ACAATCCTGTATGGCTCCGAGACCGGCCGGGCCCAGAGCTACGCACAGCAGCTGGGGAGA
CTCTTCCGGAAGGCTTTTGATCCCCGGGTCCTGTGTATGGATGAGTATGACGTGGTGTCC
CTCGAACACGAGACGCTGGTGCTGGTGGTAACCAGCACATTTGGGAATGGGGATCCCCCG
GAGAATGGAGAGAGCTTTGCAGCTGCCCTGATGGAGATGTCCGGCCCCTACAACAGCTCC
CCTCGGCCGGAACAGCACAAGAGTTATAAGATCCGCTTCAACAGCATCTCCTGCTCAGAC
CCACTGGTGTCCTCTTGGCGGCGGAAGAGGAAGGAGTCCAGTAACACAGACAGTGCAGGG
GCCCTGGGCACCCTCAGGTTCTGTGTGTTCGGGCTCGGCTCCCGGGCATACCCCCACTTC
TGCGCCTTTGCTCGTGCCGTGGACACACGGCTGGAGGAACTGGGCGGGGAGCGGCTGCTG
CAGCTGGGCCAGGGCGACGAGCTGTGCGGCCAGGAGGAGGCCTTCCGAGGCTGGGCCCAG
GCTGCCTTCCAGGCCGCCTGTGAGACCTTCTGTGTGGGAGAGGATGCCAAGGCCGCCGCC
CGAGACATCTTCAGCCCCAAACGGAGCTGGAAGCGCCAGAGGTACCGGCTGAGCGCCCAG
GCCGAGGGCCTGCAGTTGCTGCCAGGTCTGATCCACGTGCACAGGCGGAAGATGTTCCAG
GCTACAATCCGCTCAGTGGAAAACCTGCAAAGCAGCAAGTCCACGAGGGCCACCATCCTG
GTGCGCCTGGACACCGGAGGCCAGGAGGGGCTGCAGTACCAGCCGGGGGACCACATAGGT
GTCTGCCCGCCCAACCGGCCCGGCCTTGTGGAGGCGCTGCTGAGCCGCGTGGAGGACCCG
CCGGCGCCCACTGAGCCCGTGGCAGTAGAGCAGCTGGAGAAGGGCAGCCCTGGTGGCCCT
CCCCCCGGCTGGGTGCGGGACCCCCGGCTGCCCCCGTGCACGCTGCGCCAGGCTCTCACC
TTCTTCCTGGACATCACCTCCCCACCCAGCCCTCAGCTCTTGCGGCTGCTCAGCACCTTG
GCAGAAGAGCCCAGGGAACAGCAGGAGCTGGAGGCCCTCAGCCAGGATCCCCGACGCTAC
GAGGAGTGGAAGTGGTTCCGCTGCCCCACGCTGCTGGAGGTGCTGGAGCAGTTCCCGTCG
GTGGCGCTGCCTGCCCCACTGCTCCTCACCCAGCTGCCTCTGCTCCAGCCCCGGTACTAC
TCAGTCAGCTCGGCACCCAGCACCCACCCAGGAGAGATCCACCTCACTGTAGCTGTGCTG
GCATACAGGACTCAGGATGGGCTGGGCCCCCTGCACTATGGAGTCTGCTCCACGTGGCTA
AGCCAGCTCAAGCCCGGAGACCCTGTGCCCTGCTTCATCCGGGGGGCTCCCTCCTTCCGG
CTGCCACCCGATCCCAGCTTGCCCTGCATCCTGGTGGGTCCAGGCACTGGCATTGCCCCC
TTCCGGGGATTCTGGCAGGAGCGGCTGCATGACATTGAGAGCAAAGGGCTGCAGCCCACT
CCCATGACTTTGGTGTTCGGCTGCCGATGCTCCCAACTTGACCATCTCTACCGCGACGAG
GTGCAGAACGCCCAGCAGCGCGGGGTGTTTGGCCGAGTCCTCACCGCCTTCTCCCGGGAA
CCTGACAACCCCAAGACCTACGTGCAGGACATCCTGAGGACGGAGCTGGCTGCGGAGGTG
CACCGCGTGCTGTGCCTCGAGCGGGGCCACATGTTTGTCTGCGGCGATGTTACCATGGCA
ACCAACGTCCTGCAGACCGTGCAGCGCATCCTGGCGACGGAGGGCGACATGGAGCTGGAC
GAGGCCGGCGACGTCATCGGCGTGCTGCGGGATCAGCAACGCTACCACGAAGACATTTTC
GGGCTCACGCTGCGCACCCAGGAGGTGACAAGCCGCATACGCACCCAGAGCTTTTCCTTG
CAGGAGCGTCAGTTGCGGGGCGCAGTGCCCTGGGCGTTCGACCCTCCCGGCTCAGACACC
AACAGCCCCTGA
|
| Target 1 GenBank Gene ID |
|
| Target 1 GeneCard ID |
NOS3  |
| Target 1 GenAtlas ID |
NOS3  |
| Target 1 HGNC ID |
HGNC:7876  |
| Target 1 Chromosome Location |
7 |
| Target 1 Locus |
7q36 |
| Target 1 SNPs |
SNPJam Report  |
| Target 1 General References |
- Fischmann TO, Hruza A, Niu XD, Fossetta JD, Lunn CA, Dolphin E, Prongay AJ, Reichert P, Lundell DJ, Narula SK, Weber PC: Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat Struct Biol. 1999 Mar;6(3):233-42. [PubMed
]
- Rosenfeld RJ, Garcin ED, Panda K, Andersson G, Aberg A, Wallace AV, Morris GM, Olson AJ, Stuehr DJ, Tainer JA, Getzoff ED: Conformational changes in nitric oxide synthases induced by chlorzoxazone and nitroindazoles: crystallographic and computational analyses of inhibitor potency. Biochemistry. 2002 Nov 26;41(47):13915-25. [PubMed
]
- Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD: Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem. 1992 Jul 25;267(21):14519-22. [PubMed
]
- Marsden PA, Schappert KT, Chen HS, Flowers M, Sundell CL, Wilcox JN, Lamas S, Michel T: Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett. 1992 Aug 3;307(3):287-93. [PubMed
]
- Sase K, Michel T: Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci. 1995;57(22):2049-55. [PubMed
]
- Nadaud S, Bonnardeaux A, Lathrop M, Soubrier F: Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun. 1994 Feb 15;198(3):1027-33. [PubMed
]
- Robinson LJ, Weremowicz S, Morton CC, Michel T: Isolation and chromosomal localization of the human endothelial nitric oxide synthase (NOS3) gene. Genomics. 1994 Jan 15;19(2):350-7. [PubMed
]
- Miyahara K, Kawamoto T, Sase K, Yui Y, Toda K, Yang LX, Hattori R, Aoyama T, Yamamoto Y, Doi Y, et al.: Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur J Biochem. 1994 Aug 1;223(3):719-26. [PubMed
]
- Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappert KT: Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993 Aug 15;268(23):17478-88. [PubMed
]
- Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, Ogawa H, Ogawa Y, Saito Y, Miyamoto Y, Nakao K: A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet. 1998 Jul;103(1):65-9. [PubMed
]
|
| Target 1 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|
|
Drug Target 2
[top]
|
| Target 2 ID |
756 |
| Target 2 Name |
Sex hormone-binding globulin |
| Target 2 Synonyms |
- ABP
- SBP
- SHBG
- Sex hormone-binding globulin precursor
- Sex steroid-binding protein
- TeBG
- Testis-specific androgen-binding protein
- Testosterone-estradiol- binding globulin
- Testosterone-estrogen-binding globulin
|
| Target 2 Gene Name |
SHBG |
| Target 2 Protein Sequence |
>Sex hormone-binding globulin precursor
MESRGPLATSRLLLLLLLLLLRHTRQGWALRPVLPTQSAHDPPAVHLSNGPGQEPIAVMT
FDLTKITKTSSSFEVRTWDPEGVIFYGDTNPKDDWFMLGLRDGRPEIQLHNHWAQLTVGA
GPRLDDGRWHQVEVKMEGDSVLLEVDGEEVLRLRQVSGPLTSKRHPIMRIALGGLLFPAS
NLRLPLVPALDGCLRRDSWLDKQAEISASAPTSLRSCDVESNPGIFLPPGTQAEFNLRDI
PQPHAEPWAFSLDLGLKQAAGSGHLLALGTPENPSWLSLHLQDQKVVLSSGSGPGLDLPL
VLGLPLQLKLSMSRVVLSQGSKMKALALPPLGLAPLLNLWAKPQGRLFLGALPGEDSSTS
FCLNGLWAQGQRLDVDQALNRSHEIWTHSCPQSPGNGTDASH
|
| Target 2 Number of Residues |
408 |
| Target 2 Molecular Weight |
43780 |
| Target 2 Theoretical pI |
6.70 |
| Target 2 GO Classification |
Not Available |
| Target 2 General Function |
Involved in androgen binding |
| Target 2 Specific Function |
Functions as an androgen transport protein, but may also be involved in receptor mediated processes. Each dimer binds one molecule of steroid. Specific for 5-alpha-dihydrotestosterone, testosterone, and 17-beta-estradiol. Regulates the plasma metabolic clearance rate of steroid hormones by controlling their plasma concentration |
| Target 2 Pathways |
Not Available
|
| Target 2 Reactions |
Not Available |
| Target 2 Pfam Domain Function |
|
| Target 2 Signals |
|
| Target 2 Transmembrane Regions |
|
| Target 2 Essentiality |
Non-Essential |
| Target 2 GenBank ID Protein |
296673  |
| Target 2 UniProtKB/Swiss-Prot ID |
P04278  |
| Target 2 UniProtKB/Swiss-Prot Entry Name |
SHBG_HUMAN  |
| Target 2 PDB ID |
1F5F  |
| Target 2 PDB File |
Show |
| Target 2 3D Structure |
|
| Target 2 Cellular Location |
- Secreted protein. In testis, it is synthesized by the Sertoli cells, secreted into the lumen of the
|
| Target 2 Gene Sequence |
>1209 bp
ATGGAGAGCAGAGGCCCACTGGCTACCTCGCGCCTGCTGCTGTTGCTGCTGTTGCTACTA
CTGCGTCACACCCGCCAGGGATGGGCCCTGAGACCTGTTCTCCCCACCCAGAGTGCCCAC
GACCCTCCGGCTGTCCACCTCAGCAATGGCCCAGGACAAGAGCCTATCGCTGTCATGACC
TTTGACCTCACCAAGATCACAAAAACCTCCTCCTCCTTTGAGGTTCGAACCTGGGACCCA
GAGGGAGTGATTTTTTATGGGGATACCAACCCTAAGGATGACTGGTTTATGCTGGGACTT
CGAGACGGCAGGCCTGAGATCCAACTGCACAATCACTGGGCCCAGCTTACGGTGGGTGCT
GGACCACGGCTGGATGATGGGAGATGGCACCAGGTGGAAGTCAAGATGGAGGGGGACTCT
GTGCTGCTGGAGGTGGATGGGGAGGAGGTGCTGCGCCTGAGACAGGTCTCTGGGCCCCTG
ACCAGCAAACGCCATCCCATCATGAGGATTGCGCTTGGGGGGCTGCTCTTCCCCGCTTCC
AACCTTCGGTTGCCGCTGGTTCCTGCCCTGGATGGCTGCCTGCGCCGGGATTCCTGGCTG
GACAAACAGGCCGAGATCTCAGCATCTGCCCCCACTAGCCTCAGAAGCTGTGATGTAGAA
TCAAATCCCGGGATATTTCTCCCTCCAGGGACTCAGGCAGAATTCAATCTCCGAGACATT
CCCCAGCCTCATGCAGAGCCCTGGGCCTTCTCTTTGGACCTGGGACTCAAGCAGGCAGCA
GGCTCAGGCCACCTCCTTGCTCTTGGGACACCAGAGAACCCATCTTGGCTCAGTCTCCAC
CTCCAAGATCAAAAGGTGGTGTTGTCTTCTGGGTCGGGGCCAGGGCTGGATCTGCCCCTG
GTCTTGGGACTCCCTCTTCAGCTGAAGCTGAGTATGTCCAGGGTGGTCTTGAGCCAAGGG
TCGAAGATGAAGGCCCTTGCCCTGCCTCCCTTAGGCCTGGCTCCCCTCCTTAACCTCTGG
GCCAAGCCTCAAGGGCGTCTCTTCCTGGGGGCTTTACCAGGAGAAGACTCTTCCACCTCT
TTTTGCCTGAATGGCCTTTGGGCACAAGGTCAGAGGCTGGATGTGGACCAGGCCCTGAAC
AGAAGCCATGAGATCTGGACTCACAGCTGCCCCCAGAGCCCAGGCAATGGCACTGACGCT
TCCCATTAA
|
| Target 2 GenBank Gene ID |
|
| Target 2 GeneCard ID |
SHBG  |
| Target 2 GenAtlas ID |
SHBG  |
| Target 2 HGNC ID |
HGNC:10839  |
| Target 2 Chromosome Location |
17 |
| Target 2 Locus |
17p13-p12 |
| Target 2 SNPs |
SNPJam Report  |
| Target 2 General References |
- Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet. 1999 Jul;22(3):231-8. [PubMed
]
- Grishkovskaya I, Avvakumov GV, Sklenar G, Dales D, Hammond GL, Muller YA: Crystal structure of human sex hormone-binding globulin: steroid transport by a laminin G-like domain. EMBO J. 2000 Feb 15;19(4):504-12. [PubMed
]
- Grishkovskaya I, Avvakumov GV, Hammond GL, Catalano MG, Muller YA: Steroid ligands bind human sex hormone-binding globulin in specific orientations and produce distinct changes in protein conformation. J Biol Chem. 2002 Aug 30;277(35):32086-93. Epub 2002 Jun 13. [PubMed
]
- Power SG, Bocchinfuso WP, Pallesen M, Warmels-Rodenhiser S, Van Baelen H, Hammond GL: Molecular analyses of a human sex hormone-binding globulin variant: evidence for an additional carbohydrate chain. J Clin Endocrinol Metab. 1992 Oct;75(4):1066-70. [PubMed
]
- Gershagen S, Lundwall A, Fernlund P: Characterization of the human sex hormone binding globulin (SHBG) gene and demonstration of two transcripts in both liver and testis. Nucleic Acids Res. 1989 Nov 25;17(22):9245-58. [PubMed
]
- Hammond GL, Underhill DA, Rykse HM, Smith CL: The human sex hormone-binding globulin gene contains exons for androgen-binding protein and two other testicular messenger RNAs. Mol Endocrinol. 1989 Nov;3(11):1869-76. [PubMed
]
- Que BG, Petra PH: Characterization of a cDNA coding for sex steroid-binding protein of human plasma. FEBS Lett. 1987 Jul 27;219(2):405-9. [PubMed
]
- Gershagen S, Fernlund P, Lundwall A: A cDNA coding for human sex hormone binding globulin. Homology to vitamin K-dependent protein S. FEBS Lett. 1987 Aug 10;220(1):129-35. [PubMed
]
- Walsh KA, Titani K, Takio K, Kumar S, Hayes R, Petra PH: Amino acid sequence of the sex steroid binding protein of human blood plasma. Biochemistry. 1986 Nov 18;25(23):7584-90. [PubMed
]
- Hammond GL, Underhill DA, Smith CL, Goping IS, Harley MJ, Musto NA, Cheng CY, Bardin CW: The cDNA-deduced primary structure of human sex hormone-binding globulin and location of its steroid-binding domain. FEBS Lett. 1987 May 4;215(1):100-4. [PubMed
]
- 3702459 Hammond GL, Robinson PA, Sugino H, Ward DN, Finne J: Physicochemical characteristics of human sex hormone binding globulin: evidence for two identical subunits. J Steroid Biochem. 1986 Apr;24(4):815-24.
- 7714097 Hardy DO, Carino C, Catterall JF, Larrea F: Molecular characterization of a genetic variant of the steroid hormone-binding globulin gene in heterozygous subjects. J Clin Endocrinol Metab. 1995 Apr;80(4):1253-6.
|
| Target 2 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|
|
Drug Target 3
[top]
|
| Target 3 ID |
2512 |
| Target 3 Name |
Glutathione S-transferase A2 |
| Target 3 Synonyms |
- EC 2.5.1.18
- GST class-alpha member 2
- Glutathione S-transferase GT41A
|
| Target 3 Gene Name |
Gsta2 |
| Target 3 Protein Sequence |
>Glutathione S-transferase A2
MAGKPVLHYFNARGRMECIRWLLAAAGVEFEEKFIQSPEDLEKLKKDGNLMFDQVPMVEI
DGMKLVQTRAILNYIATKYDLYGKDMKERALIDMYTEGILDLTEMIGQLVLCPPDQREAK
TALAKDRTKNRYLPAFEKVLKSHGQDYLVGNRLTRVDVHLLELLLYVEELDASLLTPFPL
LKAFKSRISSLPNVKKFLQPGSQRKPPLDAKQIEEARKVFKF
|
| Target 3 Number of Residues |
225 |
| Target 3 Molecular Weight |
25533 |
| Target 3 Theoretical pI |
9.22 |
| Target 3 GO Classification |
|
Function
|
catalytic activity
transferase activity
transferase activity, transferring alkyl or aryl (other than methyl) groups
glutathione transferase activity |
|
Process
|
physiological process
metabolism |
|
Component
|
| Not Available |
|
| Target 3 General Function |
Involved in glutathione transferase activity |
| Target 3 Specific Function |
Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles |
| Target 3 Pathways |
|
| Target 3 Reactions |
- RX + glutathione = HX + R-S-glutathione
|
| Target 3 Pfam Domain Function |
|
| Target 3 Signals |
|
| Target 3 Transmembrane Regions |
|
| Target 3 Essentiality |
Essential |
| Target 3 GenBank ID Protein |
309279  |
| Target 3 UniProtKB/Swiss-Prot ID |
P10648  |
| Target 3 UniProtKB/Swiss-Prot Entry Name |
GSTA2_MOUSE  |
| Target 3 PDB ID |
1ML6  |
| Target 3 PDB File |
Show |
| Target 3 3D Structure |
|
| Target 3 Cellular Location |
Not Available |
| Target 3 Gene Sequence |
>669 bp
ATGGCCGGGAAGCCCGTGCTTCACTACTTCAATGCCCGGGGCAGAATGGAGTGCATCAGG
TGGCTCCTGGCTGCAGCAGGGGTGGAGTTTGAAGAGAAGTTTATACAGAGTCCGGAAGAT
TTGGAAAAGCTAAAAAAAGATGGGAATTTGATGTTTGACCAAGTGCCCATGGTGGAGATT
GATGGGATGAAGCTGGTGCAGACCAGAGCCATTCTCAACTACATCGCCACCAAATATGAC
CTCTATGGGAAGGACATGAAGGAGAGAGCCCTGATTGACATGTATACAGAAGGTATTTTA
GATCTGACTGAAATGATTGGGCAATTGGTATTATGTCCCCCAGACCAAAGAGAAGCCAAG
ACTGCCTTGGCAAAAGACAGGACCAAAAACCGTTACTTGCCTGCCTTTGAAAAGGTGTTG
AAGAGCCATGGACAAGACTACCTTGTGGGCAACAGGCTGACCAGGGTGGACGTCCACCTG
CTGGAACTTCTTCTCTATGTTGAAGAGCTTGATGCCAGCCTTCTGACCCCTTTCCCTCTG
CTGAAGGCCTTCAAGAGCAGAATCAGCAGCCTCCCCAATGTGAAGAAGTTCCTACAGCCT
GGCAGCCAGAGAAAGCCTCCCTTGGATGCAAAACAAATTGAAGAAGCAAGGAAGGTTTTC
AAGTTTTAG
|
| Target 3 GenBank Gene ID |
|
| Target 3 GeneCard ID |
Not Available |
| Target 3 GenAtlas ID |
Not Available |
| Target 3 HGNC ID |
Not Available |
| Target 3 Chromosome Location |
Not Available |
| Target 3 Locus |
Not Available |
| Target 3 SNPs |
SNPJam Report  |
| Target 3 General References |
- Pearson WR, Reinhart J, Sisk SC, Anderson KS, Adler PN: Tissue-specific induction of murine glutathione transferase mRNAs by butylated hydroxyanisole. J Biol Chem. 1988 Sep 15;263(26):13324-32. [PubMed
]
|
| Target 3 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|
|
Drug Target 4
[top]
|
| Target 4 ID |
2758 |
| Target 4 Name |
Adenosylmethionine-8-amino-7-oxononanoate aminotransferase |
| Target 4 Synonyms |
- 7,8-diamino-pelargonic acid aminotransferase
- DAPA aminotransferase
- EC 2.6.1.62
|
| Target 4 Gene Name |
bioA |
| Target 4 Protein Sequence |
>Adenosylmethionine-8-amino-7-oxononanoate aminotransferase
MTTDDLAFDQRHIWHPYTSMTSPLPVYPVVSAEGCELILSDGRRLVDGMSSWWAAIHGYN
HPQLNAAMKSQIDAMSHVMFGGITHAPAIELCRKLVAMTPQPLECVFLADSGSVAVEVAM
KMALQYWQAKGEARQRFLTFRNGYHGDTFGAMSVCDPDNSMHSLWKGYLPENLFAPAPQS
RMDGEWDERDMVGFARLMAAHRHEIAAVIIEPIVQGAGGMRMYHPEWLKRIRKICDREGI
LLIADEIATGFGRTGKLFACEHAEIAPDILCLGKALTGGTMTLSATLTTREVAETISNGE
AGCFMHGPTFMGNPLACAAANASLAILESGDWQQQVADIEVQLREQLAPARDAEMVADVR
VLGAIGVVETTHPVNMAALQKFFVEQGVWIRPFGKLIYLMPPYIILPQQLQRLTAAVNRA
VQDETFFCQ
|
| Target 4 Number of Residues |
436 |
| Target 4 Molecular Weight |
47336 |
| Target 4 Theoretical pI |
5.71 |
| Target 4 GO Classification |
|
Function
|
adenosylmethionine-8-amino-7-oxononanoate transaminase activity
binding
vitamin binding
pyridoxal phosphate binding
catalytic activity
transferase activity
transferase activity, transferring nitrogenous groups
transaminase activity |
|
Process
|
physiological process
metabolism
cellular metabolism
vitamin metabolism
water-soluble vitamin metabolism
biotin metabolism
biotin biosynthesis |
|
Component
|
| Not Available |
|
| Target 4 General Function |
Coenzyme transport and metabolism |
| Target 4 Specific Function |
S-adenosyl-L-methionine + 8-amino-7- oxononanoate = S-adenosyl-4-methylthio-2-oxobutanoate + 7,8- diaminononanoate |
| Target 4 Pathways |
|
| Target 4 Reactions |
- S-adenosyl-L-methionine + 8-amino-7-oxononanoate = S-adenosyl-4-methylthio-2-oxobutanoate + 7,8-diaminononanoate
|
| Target 4 Pfam Domain Function |
|
| Target 4 Signals |
|
| Target 4 Transmembrane Regions |
|
| Target 4 Essentiality |
Essential |
| Target 4 GenBank ID Protein |
457106  |
| Target 4 UniProtKB/Swiss-Prot ID |
P12995  |
| Target 4 UniProtKB/Swiss-Prot Entry Name |
BIOA_ECOLI  |
| Target 4 PDB ID |
1QJ5  |
| Target 4 PDB File |
Show |
| Target 4 3D Structure |
|
| Target 4 Cellular Location |
|
| Target 4 Gene Sequence |
>1293 bp
TTATTGGCAAAAAAATGTTTCATCCTGTACCGCGCGGTTAACCGCTGCGGTCAGACGCTG
CAACTGTTGCGGGAGAATAATATAGGGCGGCATCAGGTAAATCAGTTTGCCAAAAGGCCG
GATCCAGACACCCTGTTCGACAAAGAATTTTTGCAGCGCCGCCATATTCACCGGATGAGT
GGTTTCGACCACGCCAATGGCCCCCAGTACGCGCACATCGGCAACCATTTCGGCATCACG
GGCGGGGGCAAGTTGCTCGCGCAGCTGTACTTCAATATCCGCCACCTGTTGCTGCCAGTC
GCCAGATTCGAGAATCGCCAGGCTGGCGTTTGCTGCCGCGCAGGCCAGCGGATTGCCCAT
AAAAGTTGGCCCATGCATAAAGCAACCGGCTTCACCGTTACTGATGGTTTCTGCAACCTC
GCGCGTGGTGAGTGTGGCGGAAAGGGTCATTGTGCCGCCGGTTAAGGCTTTACCGAGGCA
CAAAATGTCCGGCGCGATTTCTGCATGTTCACAGGCAAACAGTTTCCCGGTACGACCAAA
TCCAGTGGCGATCTCGTCGGCAATCAGCAAGATACCTTCGCGATCGCATATTTTGCGGAT
TCGTTTTAACCATTCCGGATGGTACATGCGCATCCCGCCTGCGCCCTGGACAATCGGCTC
AATGATCACCGCCGCGATTTCATGACGATGCGCCGCCATCAGGCGGGCAAAGCCCACCAT
ATCGCGCTCATCCCATTCGCCATCCATGCGGCTTTGCGGGGCGGGAGCAAACAGGTTTTC
TGGCAGGTAGCCTTTCCACAGACTGTGCATTGAGTTATCCGGATCGCACACCGACATCGC
GCCAAAGGTATCGCCATGATAACCATTGCGGAAGGTCAGAAAACGCTGGCGCGCTTCGCC
TTTGGCTTGCCAGTACTGCAACGCCATTTTCATCGCCACTTCCACCGCTACGGAACCGGA
GTCCGCGAGAAAAACGCACTCCAGCGCGTTGCGGCCGCTCATCGCCACCAGTTTGCGGCA
CAGCTCAATGGCTGGCGCATGGGTGATACCGCCAAACATCACATGCGACATGGCATCAAT
TTGCGACTTCATCGCCGCATTAAGCTGCGGGTGATTGTAGCCGTGGATCGCCGCCCACCA
GGACGACATACCGTCAACCAGGCGTCTGCCGTCAGACAAAATCAGCTCGCAACCTTCGGC
GCTCACCACCGGATAAACCGGCAGAGGGGAGGTCATGGATGTGTATGGGTGCCAGATATG
GCGTTGGTCAAAGGCAAGATCGTCCGTTGTCAT
|
| Target 4 GenBank Gene ID |
|
| Target 4 GeneCard ID |
Not Available |
| Target 4 GenAtlas ID |
Not Available |
| Target 4 HGNC ID |
Not Available |
| Target 4 Chromosome Location |
Not Available |
| Target 4 Locus |
Not Available |
| Target 4 SNPs |
SNPJam Report  |
| Target 4 General References |
- Kack H, Sandmark J, Gibson K, Schneider G, Lindqvist Y: Crystal structure of diaminopelargonic acid synthase: evolutionary relationships between pyridoxal-5'-phosphate-dependent enzymes. J Mol Biol. 1999 Aug 27;291(4):857-76. [PubMed
]
- Otsuka AJ, Buoncristiani MR, Howard PK, Flamm J, Johnson C, Yamamoto R, Uchida K, Cook C, Ruppert J, Matsuzaki J: The Escherichia coli biotin biosynthetic enzyme sequences predicted from the nucleotide sequence of the bio operon. J Biol Chem. 1988 Dec 25;263(36):19577-85. [PubMed
]
- Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74. [PubMed
]
|
| Target 4 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|
|
Drug Target 5
[top]
|
| Target 5 ID |
2773 |
| Target 5 Name |
GTPase HRas |
| Target 5 Synonyms |
- GTPase HRas precursor
- H-Ras-1
- Transforming protein p21
- c-H-ras
- p21ras
|
| Target 5 Gene Name |
Hras1 |
| Target 5 Protein Sequence |
>GTPase HRas precursor
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAG
QEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDL
AARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQHKLRKLNPPDESGLG
CMSCKCVLS
|
| Target 5 Number of Residues |
192 |
| Target 5 Molecular Weight |
21314 |
| Target 5 Theoretical pI |
4.94 |
| Target 5 GO Classification |
|
Function
|
binding
nucleotide binding
purine nucleotide binding
guanyl nucleotide binding
GTP binding |
|
Process
|
cellular process
cell communication
signal transduction
intracellular signaling cascade
small GTPase mediated signal transduction |
|
Component
|
| Not Available |
|
| Target 5 General Function |
Involved in GTP binding |
| Target 5 Specific Function |
Ras proteins bind GDP/GTP and possess intrinsic GTPase activity |
| Target 5 Pathways |
Not Available
|
| Target 5 Reactions |
Not Available |
| Target 5 Pfam Domain Function |
|
| Target 5 Signals |
|
| Target 5 Transmembrane Regions |
|
| Target 5 Essentiality |
Essential |
| Target 5 GenBank ID Protein |
206559  |
| Target 5 UniProtKB/Swiss-Prot ID |
P20171  |
| Target 5 UniProtKB/Swiss-Prot Entry Name |
RASH_RAT  |
| Target 5 PDB ID |
4Q21  |
| Target 5 PDB File |
Show |
| Target 5 3D Structure |
|
| Target 5 Cellular Location |
- Cell membrane
- Golgi apparatus membrane
- cytoplasmic side. Golgi apparatus
- lipid-anch
- lipid-anchor
|
| Target 5 Gene Sequence |
>570 bp
ATGACAGAATACAAGCTTGTGGTGGTGGGCGCTGGAGGCGTGGGAAAGAGTGCCCTGACC
ATCCAGCTGATCCAGAACCATTTTGTGGACGAGTATGATCCCACTATAGAGGACTCCTAC
CGGAAACAGGTAGTCATTGATGGGGAGACGTGTTTACTGGACATCTTAGACACAGCAGGT
CAAGAAGAGTATAGTGCCATGCGGGACCAGTACATGCGCACAGGGGAGGGCTTCCTCTGT
GTATTTGCCATCAACAACACCAAGTCCTTTGAAGACATCCATCAGTACAGGGAGCAGATC
AAGCGGGTGAAAGATTCAGATGATGTGCCAATGGTGCTGGTGGGCAACAAGTGTGACCTG
GCTGCTCGCACTGTTGAGTCTCGGCAGGCCCAGGACCTTGCTCGCAGCTATGGCATCCCC
TACATTGAAACATCAGCCAAGACCCGGCAGGGTGTGGAGGATGCCTTCTACACACTAGTA
CGTGAGATTCGGCAGCATAAACTGCGGAAACTGAACCCGCCTGATGAGAGTGGCCTTGGC
TGCATGAGCTGCAAGTGTGTGCTGTCCTGA
|
| Target 5 GenBank Gene ID |
|
| Target 5 GeneCard ID |
Not Available |
| Target 5 GenAtlas ID |
Not Available |
| Target 5 HGNC ID |
Not Available |
| Target 5 Chromosome Location |
Not Available |
| Target 5 Locus |
Not Available |
| Target 5 SNPs |
SNPJam Report  |
| Target 5 General References |
- Kelley GG, Reks SE, Ondrako JM, Smrcka AV: Phospholipase C(epsilon): a novel Ras effector. EMBO J. 2001 Feb 15;20(4):743-54. [PubMed
]
- Ruta M, Wolford R, Dhar R, Defeo-Jones D, Ellis RW, Scolnick EM: Nucleotide sequence of the two rat cellular rasH genes. Mol Cell Biol. 1986 May;6(5):1706-10. [PubMed
]
- Clarke S, Vogel JP, Deschenes RJ, Stock J: Posttranslational modification of the Ha-ras oncogene protein: evidence for a third class of protein carboxyl methyltransferases. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4643-7. [PubMed
]
|
| Target 5 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|
|
Drug Target 6
[top]
|
| Target 6 ID |
2907 |
| Target 6 Name |
Oxysterols receptor LXR-beta |
| Target 6 Synonyms |
- Liver X receptor beta
- Nuclear orphan receptor LXR-beta
- Nuclear receptor NER
- Ubiquitously-expressed nuclear receptor
|
| Target 6 Gene Name |
NR1H2 |
| Target 6 Protein Sequence |
>Oxysterols receptor LXR-beta
MSSPTTSSLDTPLPGNGPPQPGAPSSSPTVKEEGPEPWPGGPDPDVPGTDEASSACSTDW
VIPDPEEEPERKRKKGPAPKMLGHELCRVCGDKASGFHYNVLSCEGCKGFFRRSVVRGGA
RRYACRGGGTCQMDAFMRRKCQQCRLRKCKEAGMREQCVLSEEQIRKKKIRKQQQQESQS
QSQSPVGPQGSSSSASGPGASPGGSEAGSQGSGEGEGVQLTAAQELMIQQLVAAQLQCNK
RSFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQ
IALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAM
RRLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPR
MLMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHE
|
| Target 6 Number of Residues |
468 |
| Target 6 Molecular Weight |
51102 |
| Target 6 Theoretical pI |
7.80 |
| Target 6 GO Classification |
|
Function
|
signal transducer activity
receptor activity
ligand-dependent nuclear receptor activity
steroid hormone receptor activity
binding
nucleic acid binding
DNA binding
transcription factor activity |
|
Process
|
regulation of biological process
regulation of physiological process
regulation of metabolism
regulation of cellular metabolism
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolism
regulation of transcription
regulation of transcription, DNA-dependent |
|
Component
|
organelle
membrane-bound organelle
intracellular membrane-bound organelle
nucleus |
|
| Target 6 General Function |
Involved in transcription factor activity |
| Target 6 Specific Function |
Orphan receptor. Binds preferentially to double-stranded oligonucleotide direct repeats having the consensus half-site sequence 5'-AGGTCA-3' and 4-nt spacing (DR-4) |
| Target 6 Pathways |
Not Available
|
| Target 6 Reactions |
Not Available |
| Target 6 Pfam Domain Function |
|
| Target 6 Signals |
|
| Target 6 Transmembrane Regions |
|
| Target 6 Essentiality |
Non-Essential |
| Target 6 GenBank ID Protein |
641962  |
| Target 6 UniProtKB/Swiss-Prot ID |
P55055  |
| Target 6 UniProtKB/Swiss-Prot Entry Name |
NR1H2_HUMAN  |
| Target 6 PDB ID |
1UPW  |
| Target 6 PDB File |
Show |
| Target 6 3D Structure |
|
| Target 6 Cellular Location |
|
| Target 6 Gene Sequence |
>1386 bp
ATGTCCTCTCCTACCACGAGTTCCCTGGATACCCCCCTGCCTGGAAATGGCCCCCCTCAG
CCTGGCGCCCCTTCTTCTTCACCCACTGTAAAGGAGGAGGGTCCGGAGCCGTGGCCCGGG
GGTCCGGACCCTGATGTCCCAGGCACTGATGAGGCCAGCTCAGCCTGCAGCACAGACTGG
GTCATCCCAGATCCCGAAGAGGAACCAGAGCGCAAGCGAAAGAAGGGCCCAGCCCCGAAG
ATGCTGGGCCACGAGCTTTGCCGTGTCTGTGGGGACAAGGCCTCCGGCTTCCACTACAAC
GTGCTCAGCTGCGAAGGCTGCAAGGGCTTCTTCCGGCGCAGTGTGGTCCGTGGTGGGGCC
AGGCGCTATGCCTGCCGGGGTGGCGGAACCTGCCAGATGGACGCTTTCATGCGGCGCAAG
TGCCAGCAGTGCCGGCTGCGCAAGTGCAAGGAGGCAGGGATGAGGGAGCAGTGCGTCCTT
TCTGAAGAACAGATCCGGAAGAAGAAGATTCGGAAACAGCAGCAGCAGGAGTCACAGTCA
CAGTCGCAGTCACCTGTGGGGCCGCAGGGCAGCAGCAGCTCAGCCTCTGGGCCTGGGGCT
TCCCCTGGTGGATCTGAGGCAGGCAGCCAGGGCTCCGGGGAAGGCGAGGGTGTCCAGCTA
ACAGCGGCTCAAGAACTAATGATCCAGCAGTTGGTGGCGGCCCAACTGCAGTGCAACAAA
CGCTCCTTCTCCGACCAGCCCAAAGTCACGCCCTGGCCCCTGGGCGCAGACCCCCAGTCC
CGAGATGCCCGCCAGCAACGCTTTGCCCACTTCACGGAGCTGGCCATCATCTCAGTCCAG
GAGATCGTGGACTTCGCTAAGCAAGTGCCTGGTTTCCTGCAGCTGGGCCGGGAGGACCAG
ATCGCCCTCCTGAAGGCATCCACTATCGAGATCATGCTGCTAGAGACAGCCAGGCGCTAC
AACCACGAGACAGAGTGTATCACCTTCTTGAAGGACTTCACCTACAGCAAGGACGACTTC
CACCGTGCAGGCCTGCAGGTGGAGTTCATCAACCCCATCTTCGAGTTCTCGCGGGCCATG
CGGCGGCTGGGCCTGGACGACGCTGAGTACGCCCTGCTCATCGCCATCAACATCTTCTCG
GCCGACCGGCCCAACGTGCAGGAGCCGGGCCGCGTGGAGGCGTTGCAGCAGCCCTACGTG
GAGGCGCTGCTGTCCTACACGCGCATCAAGAGGCCGCAGGACCAGCTGCGCTTCCCGCGC
ATGCTCATGAAGCTGGTGAGCCTGCGCACGCTGAGCTCTGTGCACTCGGAGCAGGTCTTC
GCCTTGCGGCTCCAGGACAAGAAGCTGCCGCCTCTGCTGTCGGAGATCTGGGACGTCCAC
GAGTGA
|
| Target 6 GenBank Gene ID |
|
| Target 6 GeneCard ID |
NR1H2  |
| Target 6 GenAtlas ID |
NR1H2  |
| Target 6 HGNC ID |
HGNC:7965  |
| Target 6 Chromosome Location |
19 |
| Target 6 Locus |
19q13.3-19q13.3 |
| Target 6 SNPs |
SNPJam Report  |
| Target 6 General References |
- Shinar DM, Endo N, Rutledge SJ, Vogel R, Rodan GA, Schmidt A: NER, a new member of the gene family encoding the human steroid hormone nuclear receptor. Gene. 1994 Sep 30;147(2):273-6. [PubMed
]
|
| Target 6 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|
|
Drug Target 7
[top]
|
| Target 7 ID |
3040 |
| Target 7 Name |
Putative 1-aminocyclopropane-1-carboxylate deaminase |
| Target 7 Synonyms |
- ACC deaminase
- EC 3.5.99.7
|
| Target 7 Gene Name |
Not Available |
| Target 7 Protein Sequence |
>Putative 1-aminocyclopropane-1-carboxylate deaminase
MHPKIFALLAKFPRVELIPWETPIQYLPNISREIGADVYIKRDDLTGLGIGGNKIRKLEY
LLGDALSKGADVVITVGAVHSNHAFVTGLAAKKLGLDAILVLRGKEELKGNYLLDKIMGI
ETRVYDAKDSFELMKYAEEIAEELKREGRKPYVIPPGGASPIGTLGYVRAVGEIATQSEV
KFDSIVVAAGSGGTLAGLSLGLSILNEDIRPVGIAVGRFGEVMTSKLDNLIKEAAELLGV
KVEVRPELYDYSFGEYGKITGEVAQIIRKVGTREGIILDPVYTGKAFYGLVDLARKGELG
EKILFIHTGGISGTFHYGDKLLSLL
|
| Target 7 Number of Residues |
330 |
| Target 7 Molecular Weight |
35188 |
| Target 7 Theoretical pI |
6.70 |
| Target 7 GO Classification |
|
Function
|
| catalytic activity |
|
Process
|
physiological process
metabolism |
|
Component
|
| Not Available |
|
| Target 7 General Function |
Amino acid transport and metabolism |
| Target 7 Specific Function |
1-aminocyclopropane-1-carboxylate + H(2)O = 2- oxobutanoate + NH(3) |
| Target 7 Pathways |
|
| Target 7 Reactions |
- 1-aminocyclopropane-1-carboxylate + H2O = 2-oxobutanoate + NH3
|
| Target 7 Pfam Domain Function |
|
| Target 7 Signals |
|
| Target 7 Transmembrane Regions |
|
| Target 7 Essentiality |
Essential |
| Target 7 GenBank ID Protein |
3256439  |
| Target 7 UniProtKB/Swiss-Prot ID |
O57809  |
| Target 7 UniProtKB/Swiss-Prot Entry Name |
1A1D_PYRHO  |
| Target 7 PDB ID |
1J0B  |
| Target 7 PDB File |
Show |
| Target 7 3D Structure |
|
| Target 7 Cellular Location |
Not Available |
| Target 7 Gene Sequence |
>987 bp
CTAAAGTAGTGACAAAAGTTTGTCACCATAGTGGAACGTTCCCGATATCCCTCCAGTATG
GATAAAGAGAATCTTCTCCCCCAACTCCCCTTTCCTAGCTAGATCAACGAGCCCATAGAA
TGCCTTCCCCGTATATACGGGATCCAGTATTATTCCTTCCCTCGTTCCAACTTTCCTTAT
AATTTGAGCAACTTCACCGGTTATCTTACCGTACTCTCCAAAGCTGTAGTCGTATAACTC
CGGCCTTACCTCAACCTTTACTCCAAGTAACTCCGCAGCTTCTTTAATTAAGTTGTCCAG
CTTACTAGTCATTACTTCACCGAATCTACCAACTGCGATTCCTACGGGTCTAATATCTTC
ATTAAGGATCGACAAGCCCAGGGATAATCCTGCAAGCGTACCTCCACTTCCAGCTGCTAC
AACTATGCTATCGAATTTAACTTCGCTCTGCGTTGCAATCTCTCCAACGGCCCTAACGTA
ACCAAGCGTCCCTATTGGGGATGCTCCTCCCGGTGGAATAACATAGGGCTTCCTACCCTC
TCTTTTCAATTCCTCCGCGATCTCCTCAGCATACTTCATGAGCTCAAAGGAGTCCTTTGC
ATCATACACCCTTGTTTCGATGCCCATGATCTTATCTAGAAGGTAGTTTCCTTTCAGCTC
TTCCTTCCCCCTTAAAACTAGGATTGCATCAAGCCCAAGTTTCTTGGCGGCTAGTCCAGT
AACGAATGCATGATTGGAATGCACTGCTCCCACAGTTATTACGACGTCTGCTCCTTTAGA
GAGAGCGTCACCCAGGAGATATTCGAGCTTCCTTATTTTATTCCCCCCAATTCCGAGACC
AGTTAGATCATCCCTTTTGATATATACGTCGGCTCCTATTTCTCTACTTATGTTAGGAAG
GTACTGTATGGGTGTCTCCCAGGGGATTAACTCAACCCTTGGAAATTTAGCAAGAAGAGC
AAAGATCTTCGGATGCATATTCACCAC
|
| Target 7 GenBank Gene ID |
|
| Target 7 GeneCard ID |
Not Available |
| Target 7 GenAtlas ID |
Not Available |
| Target 7 HGNC ID |
Not Available |
| Target 7 Chromosome Location |
Not Available |
| Target 7 Locus |
Not Available |
| Target 7 SNPs |
Not Available |
| Target 7 General References |
- Kawarabayasi Y, Sawada M, Horikawa H, Haikawa Y, Hino Y, Yamamoto S, Sekine M, Baba S, Kosugi H, Hosoyama A, Nagai Y, Sakai M, Ogura K, Otsuka R, Nakazawa H, Takamiya M, Ohfuku Y, Funahashi T, Tanaka T, Kudoh Y, Yamazaki J, Kushida N, Oguchi A, Aoki K, Kikuchi H: Complete sequence and gene organization of the genome of a hyper-thermophilic archaebacterium, Pyrococcus horikoshii OT3. DNA Res. 1998 Apr 30;5(2):55-76. [PubMed
]
|
| Target 7 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|
|
Drug Target 8
[top]
|
| Target 8 ID |
3103 |
| Target 8 Name |
ABC transporter ATP-binding protein MJ0796 |
| Target 8 Synonyms |
Not Available |
| Target 8 Gene Name |
Not Available |
| Target 8 Protein Sequence |
>ABC transporter ATP-binding protein MJ0796
MIKLKNVTKTYKMGEEIIYALKNVNLNIKEGEFVSIMGPSGSGKSTMLNIIGCLDKPTEG
EVYIDNIKTNDLDDDELTKIRRDKIGFVFQQFNLIPLLTALENVELPLIFKYRGAMSGEE
RRKRALECLKMAELEERFANHKPNQLSGGQQQRVAIARALANNPPIILADEPTGALDSKT
GEKIMQLLKKLNEEDGKTVVVVTHDINVARFGERIIYLKDGEVEREEKLRGFDDR
|
| Target 8 Number of Residues |
238 |
| Target 8 Molecular Weight |
26566 |
| Target 8 Theoretical pI |
5.96 |
| Target 8 GO Classification |
|
Function
|
ATPase activity
purine nucleotide binding
adenyl nucleotide binding
ATP binding
catalytic activity
hydrolase activity
hydrolase activity, acting on acid anhydrides
hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
pyrophosphatase activity
nucleoside-triphosphatase activity
binding
nucleotide binding |
|
Process
|
| Not Available |
|
Component
|
| Not Available |
|
| Target 8 General Function |
Defense mechanisms and drug transport |
| Target 8 Specific Function |
Not Available |
| Target 8 Pathways |
Not Available
|
| Target 8 Reactions |
Not Available |
| Target 8 Pfam Domain Function |
|
| Target 8 Signals |
|
| Target 8 Transmembrane Regions |
|
| Target 8 Essentiality |
Essential |
| Target 8 GenBank ID Protein |
1591493  |
| Target 8 UniProtKB/Swiss-Prot ID |
Q58206  |
| Target 8 UniProtKB/Swiss-Prot Entry Name |
Y796_METJA  |
| Target 8 PDB ID |
1L2T  |
| Target 8 PDB File |
Show |
| Target 8 3D Structure |
|
| Target 8 Cellular Location |
|
| Target 8 Gene Sequence |
>708 bp
ATGATTAAACTCAAAAATGTAACAAAAACATACAAAATGGGAGAAGAAATTATTTATGCT
CTAAAAAATGTAAATCTGAATATAAAAGAGGGAGAGTTTGTTTCGATTATGGGTCCTTCT
GGCAGTGGAAAATCAACAATGTTAAATATTATTGGCTGTTTAGACAAACCAACAGAGGGA
GAGGTTTATATTGATAATATAAAGACCAATGACTTAGATGATGATGAATTAACAAAAATT
AGAAGAGATAAAATTGGTTTTGTCTTTCAGCAATTCAACTTAATTCCTTTATTAACTGCC
TTAGAAAATGTTGAACTTCCACTGATTTTTAAATATAGGGGAGCAATGAGCGGAGAAGAG
AGGAGGAAGAGAGCTTTAGAATGCTTAAAGATGGCAGAGTTGGAGGAGAGATTTGCCAAT
CACAAACCAAATCAGTTGAGTGGAGGGCAACAACAGAGAGTTGCTATAGCGAGGGCTTTG
GCAAACAACCCACCAATTATATTGGCGGATGAGCCAACTGGAGCATTAGATAGCAAAACA
GGAGAAAAGATAATGCAATTATTAAAAAAATTAAATGAAGAGGATGGAAAAACCGTTGTT
GTTGTTACCCATGATATAAATGTTGCGAGATTTGGAGAGAGAATAATTTATTTAAAAGAT
GGAGAGGTTGAGAGGGAAGAAAAATTGAGGGGATTTGATGATAGATAA
|
| Target 8 GenBank Gene ID |
|
| Target 8 GeneCard ID |
Not Available |
| Target 8 GenAtlas ID |
Not Available |
| Target 8 HGNC ID |
Not Available |
| Target 8 Chromosome Location |
Not Available |
| Target 8 Locus |
Not Available |
| Target 8 SNPs |
Not Available |
| Target 8 General References |
- Yuan YR, Blecker S, Martsinkevich O, Millen L, Thomas PJ, Hunt JF: The crystal structure of the MJ0796 ATP-binding cassette. Implications for the structural consequences of ATP hydrolysis in the active site of an ABC transporter. J Biol Chem. 2001 Aug 24;276(34):32313-21. Epub 2001 Jun 11. [PubMed
]
- Smith PC, Karpowich N, Millen L, Moody JE, Rosen J, Thomas PJ, Hunt JF: ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol Cell. 2002 Jul;10(1):139-49. [PubMed
]
- Bult CJ, White O, Olsen GJ, Zhou L, Fleischmann RD, Sutton GG, Blake JA, FitzGerald LM, Clayton RA, Gocayne JD, Kerlavage AR, Dougherty BA, Tomb JF, Adams MD, Reich CI, Overbeek R, Kirkness EF, Weinstock KG, Merrick JM, Glodek A, Scott JL, Geoghagen NS, Venter JC: Complete genome sequence of the methanogenic archaeon, Methanococcus jannaschii. Science. 1996 Aug 23;273(5278):1058-73. [PubMed
]
|
| Target 8 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|
|
Drug Target 9
[top]
|
| Target 9 ID |
3338 |
| Target 9 Name |
Small inducible cytokine A20 |
| Target 9 Synonyms |
- Beta chemokine exodus-1
- CC chemokine LARC
- CCL20
- Liver and activation- regulated chemokine
- MIP-3-alpha
- Macrophage inflammatory protein 3 alpha
- Small inducible cytokine A20 precursor
|
| Target 9 Gene Name |
CCL20 |
| Target 9 Protein Sequence |
>Small inducible cytokine A20 precursor
MCCTKSLLLAALMSVLLLHLCGESEAASNFDCCLGYTDRILHPKFIVGFTRQLANEGCDI
NAIIFHTKKKLSVCANPKQTWVKYIVRLLSKKVKNM
|
| Target 9 Number of Residues |
97 |
| Target 9 Molecular Weight |
10762 |
| Target 9 Theoretical pI |
9.17 |
| Target 9 GO Classification |
|
Function
|
chemokine activity
signal transducer activity
receptor binding
cytokine activity |
|
Process
|
response to stimulus
response to biotic stimulus
defense response
immune response |
|
Component
|
| extracellular region |
|
| Target 9 General Function |
Involved in cytokine activity |
| Target 9 Specific Function |
Chemotactic factor that attracts lymphocytes and, slightly, neutrophils, but not monocytes. Inhibits proliferation of myeloid progenitors in colony formation assays. May be involved in formation and function of the mucosal lymphoid tissues by attracting lymphocytes and dendritic cells towards epithelial cells. C-terminal processed forms have been shown to be equally chemotactically active for leukocytes. Possesses antibacterial activity E.coli ATCC 25922 and S.aureus ATCC 29213 |
| Target 9 Pathways |
Not Available
|
| Target 9 Reactions |
Not Available |
| Target 9 Pfam Domain Function |
|
| Target 9 Signals |
|
| Target 9 Transmembrane Regions |
|
| Target 9 Essentiality |
Non-Essential |
| Target 9 GenBank ID Protein |
1790925  |
| Target 9 UniProtKB/Swiss-Prot ID |
P78556  |
| Target 9 UniProtKB/Swiss-Prot Entry Name |
CCL20_HUMAN  |
| Target 9 PDB ID |
1M8A  |
| Target 9 PDB File |
Show |
| Target 9 3D Structure |
|
| Target 9 Cellular Location |
|
| Target 9 Gene Sequence |
>291 bp
ATGTGCTGTACCAAGAGTTTGCTCCTGGCTGCTTTGATGTCAGTGCTGCTACTCCACCTC
TGCGGCGAATCAGAAGCAGCAAGCAACTTTGACTGCTGTCTTGGATACACAGACCGTATT
CTTCATCCTAAATTTATTGTGGGCTTCACACGGCAGCTGGCCAATGAAGGCTGTGACATC
AATGCTATCATCTTTCACACAAAGAAAAAGTTGTCTGTGTGCGCAAATCCAAAACAGACT
TGGGTGAAATATATTGTGCGTCTCCTCAGTAAAAAAGTCAAGAACATGTAA
|
| Target 9 GenBank Gene ID |
|
| Target 9 GeneCard ID |
CCL20  |
| Target 9 GenAtlas ID |
CCL20  |
| Target 9 HGNC ID |
HGNC:10619  |
| Target 9 Chromosome Location |
2 |
| Target 9 Locus |
2q33-q37 |
| Target 9 SNPs |
SNPJam Report  |
| Target 9 General References |
- Rossi DL, Vicari AP, Franz-Bacon K, McClanahan TK, Zlotnik A: Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. J Immunol. 1997 Feb 1;158(3):1033-6. [PubMed
]
- Hieshima K, Imai T, Opdenakker G, Van Damme J, Kusuda J, Tei H, Sakaki Y, Takatsuki K, Miura R, Yoshie O, Nomiyama H: Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem. 1997 Feb 28;272(9):5846-53. [PubMed
]
- Hromas R, Gray PW, Chantry D, Godiska R, Krathwohl M, Fife K, Bell GI, Takeda J, Aronica S, Gordon M, Cooper S, Broxmeyer HE, Klemsz MJ: Cloning and characterization of exodus, a novel beta-chemokine. Blood. 1997 May 1;89(9):3315-22. [PubMed
]
|
| Target 9 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|
|
Drug Target 10
[top]
|
| Target 10 ID |
3391 |
| Target 10 Name |
Heme oxygenase 1 |
| Target 10 Synonyms |
- EC 1.14.99.3
|
| Target 10 Gene Name |
pbsA1 |
| Target 10 Protein Sequence |
>Heme oxygenase 1
MSVNLASQLREGTKKSHSMAENVGFVKCFLKGVVEKNSYRKLVGNLYFVYSAMEEEMAKF
KDHPILSHIYFPELNRKQSLEQDLQFYYGSNWRQEVKISAAGQAYVDRVRQVAATAPELL
VAHSYTRYLGDLSGGQILKKIAQNAMNLHDGGTAFYEFADIDDEKAFKNTYRQAMNDLPI
DQATAERIVDEANDAFAMNMKMFNELEGNLIKAIGIMVFNSLTRRRSQGSTEVGLATSEG
|
| Target 10 Number of Residues |
244 |
| Target 10 Molecular Weight |
27051 |
| Target 10 Theoretical pI |
6.69 |
| Target 10 GO Classification |
|
Function
|
catalytic activity
oxidoreductase activity
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
heme oxygenase (decyclizing) activity |
|
Process
|
physiological process
metabolism
cellular metabolism
heterocycle metabolism
porphyrin metabolism
heme metabolism
heme oxidation |
|
Component
|
| Not Available |
|
| Target 10 General Function |
Involved in heme oxygenase (decyclizing) activity |
| Target 10 Specific Function |
Catalyzes the opening of the heme ring with the release of iron. Key enzyme in the synthesis of the chromophoric part of the photosynthetic antennae |
| Target 10 Pathways |
| Name |
SMPDB Link |
KEGG Link |
| Porphyrin and chlorophyll metabolism |
|
map00860  |
|
| Target 10 Reactions |
- heme + 3 AH2 + 3 O2 = biliverdin + Fe2+ + CO + 3 A + 3 H2O
|
| Target 10 Pfam Domain Function |
|
| Target 10 Signals |
|
| Target 10 Transmembrane Regions |
|
| Target 10 Essentiality |
Essential |
| Target 10 GenBank ID Protein |
1651938  |
| Target 10 UniProtKB/Swiss-Prot ID |
P72849  |
| Target 10 UniProtKB/Swiss-Prot Entry Name |
HO1_SYNY3  |
| Target 10 PDB ID |
1WE1  |
| Target 10 PDB File |
Show |
| Target 10 3D Structure |
|
| Target 10 Cellular Location |
Not Available |
| Target 10 Gene Sequence |
>723 bp
CTAGCCTTCGGAGGTGGCGAGGCCAACTTCGGTGCTGCCTTGACTGCGGCGACGGGTGAG
GCTGTTGAACACCATAATGCCGATCGCCTTGATCAGGTTGCCTTCAAGTTCGTTGAACAT
TTTCATGTTCATGGCAAAGGCGTCATTGGCTTCATCCACAATCCGTTCGGCGGTGGCTTG
GTCAATGGGCAGATCATTCATAGCTTGACGGTAGGTATTTTTAAAAGCCTTTTCGTCATC
AATGTCGGCAAATTCATAGAAAGCTGTGCCACCATCGTGGAGATTCATGGCATTTTGGGC
AATTTTCTTGAGAATTTGACCGCCGGAAAGATCCCCCAGGTAACGGGTGTAGGAATGGGC
CACCAACAATTCAGGGGCCGTAGCGGCCACTTGCCGGACTCGGTCCACATAGGCTTGGCC
AGCGGCAGAAATTTTCACTTCTTGCCGCCAGTTGGAGCCGTAATAGAATTGCAGGTCTTG
CTCTAGGCTTTGTTTGCGGTTGAGTTCGGGGAAGTAAATGTGGCTGAGGATGGGATGGTC
CTTAAATTTTGCCATTTCCTCTTCCATGGCACTGTAGACAAAGTAGAGATTGCCAACCAG
CTTACGGTAGGAATTTTTCTCGACAACGCCCTTGAGGAAGCATTTGACAAAGCCGACGTT
CTCCGCCATGGAGTGGGATTTTTTCGTCCCTTCCCGCAACTGGGAAGCTAAGTTGACACT
CAT
|
| Target 10 GenBank Gene ID |
|
| Target 10 GeneCard ID |
Not Available |
| Target 10 GenAtlas ID |
Not Available |
| Target 10 HGNC ID |
Not Available |
| Target 10 Chromosome Location |
Not Available |
| Target 10 Locus |
Not Available |
| Target 10 SNPs |
SNPJam Report  |
| Target 10 General References |
- Kaneko T, Sato S, Kotani H, Tanaka A, Asamizu E, Nakamura Y, Miyajima N, Hirosawa M, Sugiura M, Sasamoto S, Kimura T, Hosouchi T, Matsuno A, Muraki A, Nakazaki N, Naruo K, Okumura S, Shimpo S, Takeuchi C, Wada T, Watanabe A, Yamada M, Yasuda M, Tabata S: Sequence analysis of the genome of the unicellular cyanobacterium Synechocystis sp. strain PCC6803. II. Sequence determination of the entire genome and assignment of potential protein-coding regions. DNA Res. 1996 Jun 30;3(3):109-36. [PubMed
]
|
| Target 10 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|
|
Drug Target 11
[top]
|
| Target 11 ID |
3777 |
| Target 11 Name |
ATP-dependent Clp protease ATP-binding subunit clpA |
| Target 11 Synonyms |
Not Available |
| Target 11 Gene Name |
clpA |
| Target 11 Protein Sequence |
>ATP-dependent Clp protease ATP-binding subunit clpA
MLNQELELSLNMAFARAREHRHEFMTVEHLLLALLSNPSAREALEACSVDLVALRQELEA
FIEQTTPVLPASEEERDTQPTLSFQRVLQRAVFHVQSSGRNEVTGANVLVAIFSEQESQA
AYLLRKHEVSRLDVVNFISHGTRKDEPTQSSDPGSQPNSEEQAGGEERMENFTTNLNQLA
RVGGIDPLIGREKELERAIQVLCRRRKNNPLLVGESGVGKTAIAEGLAWRIVQGDVPEVM
ADCTIYSLDIGSLLAGTKYRGDFEKRFKALLKQLEQDTNSILFIDEIHTIIGAGAASGGQ
VDAANLIKPLLSSGKIRVIGSTTYQEFSNIFEKDRALARRFQKIDITEPSIEETVQIING
LKPKYEAHHDVRYTAKAVRAAVELAVKYINDRHLPDKAIDVIDEAGARARLMPVSKRKKT
VNVADIESVVARIARIPEKSVSQSDRDTLKNLGDRLKMLVFGQDKAIEALTEAIKMARAG
LGHEHKPVGSFLFAGPTGVGKTEVTVQLSKALGIELLRFDMSEYMERHTVSRLIGAPPGY
VGFDQGGLLTDAVIKHPHAVLLLDEIEKAHPDVFNILLQVMDNGTLTDNNGRKADFRNVV
LVMTTNAGVRETERKSIGLIHQDNSTDAMEEIKKIFTPEFRNRLDNIIWFDHLSTDVIHQ
VVDKFIVELQVQLDQKGVSLEVSQEARNWLAEKGYDRAMGARPMARVIQDNLKKPLANEL
LFGSLVDGGQVTVALDKEKNELTYGFQSAQKHKAEAAH
|
| Target 11 Number of Residues |
770 |
| Target 11 Molecular Weight |
84208 |
| Target 11 Theoretical pI |
6.26 |
| Target 11 GO Classification |
|
Function
|
protein binding
purine nucleotide binding
adenyl nucleotide binding
ATP binding
catalytic activity
hydrolase activity
hydrolase activity, acting on acid anhydrides
hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
pyrophosphatase activity
nucleoside-triphosphatase activity
binding
nucleotide binding |
|
Process
|
physiological process
metabolism
macromolecule metabolism
protein metabolism |
|
Component
|
| Not Available |
|
| Target 11 General Function |
Posttranslational modification, protein turnover, chaperones |
| Target 11 Specific Function |
ATP-dependent specificity component of the clpP protease. It directs the protease to specific substrates. The primary function of the clpA-clpP complex appears to be the degradation of unfolded or abnormal proteins |
| Target 11 Pathways |
Not Available
|
| Target 11 Reactions |
Not Available |
| Target 11 Pfam Domain Function |
|
| Target 11 Signals |
|
| Target 11 Transmembrane Regions |
|
| Target 11 Essentiality |
Non-Essential |
| Target 11 GenBank ID Protein |
Not Available |
| Target 11 UniProtKB/Swiss-Prot ID |
P0ABH9  |
| Target 11 UniProtKB/Swiss-Prot Entry Name |
CLPA_ECOLI  |
| Target 11 PDB ID |
1KSF  |
| Target 11 PDB File |
Show |
| Target 11 3D Structure |
|
| Target 11 Cellular Location |
|
| Target 11 Gene Sequence |
Not Available |
| Target 11 GenBank Gene ID |
|
| Target 11 GeneCard ID |
Not Available |
| Target 11 GenAtlas ID |
Not Available |
| Target 11 HGNC ID |
Not Available |
| Target 11 Chromosome Location |
Not Available |
| Target 11 Locus |
Not Available |
| Target 11 SNPs |
SNPJam Report  |
| Target 11 General References |
- Guo F, Maurizi MR, Esser L, Xia D: Crystal structure of ClpA, an Hsp100 chaperone and regulator of ClpAP protease. J Biol Chem. 2002 Nov 29;277(48):46743-52. Epub 2002 Aug 29. [PubMed
]
- Guo F, Esser L, Singh SK, Maurizi MR, Xia D: Crystal structure of the heterodimeric complex of the adaptor, ClpS, with the N-domain of the AAA+ chaperone, ClpA. J Biol Chem. 2002 Nov 29;277(48):46753-62. Epub 2002 Sep 15. [PubMed
]
- Zeth K, Ravelli RB, Paal K, Cusack S, Bukau B, Dougan DA: Structural analysis of the adaptor protein ClpS in complex with the N-terminal domain of ClpA. Nat Struct Biol. 2002 Dec;9(12):906-11. [PubMed
]
- Cummings HS, Sands JF, Foreman PC, Fraser J, Hershey JW: Structure and expression of the infA operon encoding translational initiation factor IF1. Transcriptional control by growth rate. J Biol Chem. 1991 Sep 5;266(25):16491-8. [PubMed
]
- Gottesman S, Squires C, Pichersky E, Carrington M, Hobbs M, Mattick JS, Dalrymple B, Kuramitsu H, Shiroza T, Foster T, et al.: Conservation of the regulatory subunit for the Clp ATP-dependent protease in prokaryotes and eukaryotes. Proc Natl Acad Sci U S A. 1990 May;87(9):3513-7. [PubMed
]
- Gottesman S, Clark WP, Maurizi MR: The ATP-dependent Clp protease of Escherichia coli. Sequence of clpA and identification of a Clp-specific substrate. J Biol Chem. 1990 May 15;265(14):7886-93. [PubMed
]
- Katayama Y, Gottesman S, Pumphrey J, Rudikoff S, Clark WP, Maurizi MR: The two-component, ATP-dependent Clp protease of Escherichia coli. Purification, cloning, and mutational analysis of the ATP-binding component. J Biol Chem. 1988 Oct 15;263(29):15226-36. [PubMed
]
- Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55. [PubMed
]
- Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74. [PubMed
]
|
| Target 11 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|
|
Drug Target 12
[top]
|
| Target 12 ID |
5421 |
| Target 12 Name |
Uridine phosphorylase, putative |
| Target 12 Synonyms |
- EC 2.4.2.3
|
| Target 12 Gene Name |
PFE0660c |
| Target 12 Protein Sequence |
>Uridine phosphorylase, putative
MDNLLRHLKISKEQITPVVLVVGDPGRVDKIKVVCDSYVDLAYNREYKSVECHYKGQKFL
CVSHGVGSAGCAVCFEELCQNGAKVIIRAGSCGSLQPDLIKRGDICICNAAVREDRVSHL
LIHGDFPAVGDFDVYDTLNKCAQELNVPVFNGISVSSDMYYPNKIIPSRLEDYSKANAAV
VEMELATLMVIGTLRKVKTGGILIVDGCPFKWDEGDFDNNLVPHQLENMIKIALGACAKL
ATKYA
|
| Target 12 Number of Residues |
249 |
| Target 12 Molecular Weight |
26858 |
| Target 12 Theoretical pI |
6.49 |
| Target 12 GO Classification |
|
Function
|
| catalytic activity |
|
Process
|
physiological process
metabolism
cellular metabolism
nucleobase, nucleoside, nucleotide and nucleic acid metabolism
nucleoside metabolism |
|
Component
|
| Not Available |
|
| Target 12 General Function |
Involved in catalytic activity |
| Target 12 Specific Function |
Not Available |
| Target 12 Pathways |
Not Available
|
| Target 12 Reactions |
Not Available |
| Target 12 Pfam Domain Function |
|
| Target 12 Signals |
|
| Target 12 Transmembrane Regions |
|
| Target 12 Essentiality |
Essential |
| Target 12 GenBank ID Protein |
Not Available |
| Target 12 UniProtKB/Swiss-Prot ID |
Q8I3X4  |
| Target 12 UniProtKB/Swiss-Prot Entry Name |
Q8I3X4_PLAF7  |
| Target 12 PDB ID |
1Q1G  |
| Target 12 PDB File |
Show |
| Target 12 3D Structure |
|
| Target 12 Cellular Location |
Not Available |
| Target 12 Gene Sequence |
>738 bp
TTAGGCATATTTGGTTGCTAATTTTGCACATGCTCCTAAGGCTATTTTAATCATATTTTC
TAATTGGTGAGGAACTAAATTGTTGTCGAAATCCCCTTCGTCCCATTTGAATGGACATCC
ATCAACAATAAGAATACCACCTGTTTTAACTTTTCTTAAGGTTCCAATAACCATAAGAGT
GGCTAGTTCCATTTCAACAACAGCAGCATTAGCTTTAGAATAATCTTCTAATCTTGAAGG
AATAATTTTATTGGGATAATACATATCTGATGAAACACTGATACCATTAAAAACTGGCAC
ATTCAATTCTTGTGCACATTTATTTAAAGTATCATAAACATCAAAATCACCAACAGCTGG
GAAATCTCCATGAATTAATAAATGAGATACTCTATCTTCCCTAACAGCTGCATTACATAT
ACATATGTCACCTCTTTTTATTAAATCTGGTTGAAGAGATCCACATGAACCTGCACGAAT
AATTACTTTAGCTCCATTTTGACATAATTCTTCAAAACATACAGCACATCCTGCTGAACC
TACACCGTGACTAACACATAAAAATTTCTGACCCTTATAATGACATTCTACACTTTTGTA
TTCTCTGTTGTATGCTAAATCAACATATGAATCACATACCACTTTTATCTTGTCGACTCT
TCCTGGATCTCCTACAACTAAAACAACTGGTGTTATTTGTTCCTTGCTTATTTTTAAATG
GCGTAAAAGATTATCCAT
|
| Target 12 GenBank Gene ID |
|
| Target 12 GeneCard ID |
Not Available |
| Target 12 GenAtlas ID |
Not Available |
| Target 12 HGNC ID |
Not Available |
| Target 12 Chromosome Location |
Not Available |
| Target 12 Locus |
Not Available |
| Target 12 SNPs |
SNPJam Report  |
| Target 12 General References |
- Hall N, Pain A, Berriman M, Churcher C, Harris B, Harris D, Mungall K, Bowman S, Atkin R, Baker S, Barron A, Brooks K, Buckee CO, Burrows C, Cherevach I, Chillingworth C, Chillingworth T, Christodoulou Z, Clark L, Clark R, Corton C, Cronin A, Davies R, Davis P, Dear P, Dearden F, Doggett J, Feltwell T, Goble A, Goodhead I, Gwilliam R, Hamlin N, Hance Z, Harper D, Hauser H, Hornsby T, Holroyd S, Horrocks P, Humphray S, Jagels K, James KD, Johnson D, Kerhornou A, Knights A, Konfortov B, Kyes S, Larke N, Lawson D, Lennard N, Line A, Maddison M, McLean J, Mooney P, Moule S, Murphy L, Oliver K, Ormond D, Price C, Quail MA, Rabbinowitsch E, Rajandream MA, Rutter S, Rutherford KM, Sanders M, Simmonds M, Seeger K, Sharp S, Smith R, Squares R, Squares S, Stevens K, Taylor K, Tivey A, Unwin L, Whitehead S, Woodward J, Sulston JE, Craig A, Newbold C, Barrell BG: Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13. Nature. 2002 Oct 3;419(6906):527-31. [PubMed
]
|
| Target 12 Drug References |
Not Available |
|
Drug Target 13
[top]
|
| Target 13 ID |
5659 |
| Target 13 Name |
Cag-Z |
| Target 13 Synonyms |
Not Available |
| Target 13 Gene Name |
cag-Z |
| Target 13 Protein Sequence |
>Cag-Z
MELGFNEAERQKILDSNSSLMRNANEVRDKFIQNYATSLKDSNDPQDFLRRVQELRINMQ
KNFISFDAYYNYLNNLVLASYNRCKQEKTFAESTIKNELTLGEFVAEISDNFNNFTCDEV
ARISDLVASYLPREYLPPFIDGNMMGVAFQILGIDDFGKKLNEIVQDIGTKYIILSKNKT
YLTSLERAKLITQLKLNLE
|
| Target 13 Number of Residues |
202 |
| Target 13 Molecular Weight |
23044 |
| Target 13 Theoretical pI |
4.80 |
| Target 13 GO Classification |
Not Available |
| Target 13 General Function |
Not Available |
| Target 13 Specific Function |
Not Available |
| Target 13 Pathways |
Not Available
|
| Target 13 Reactions |
Not Available |
| Target 13 Pfam Domain Function |
Not Available |
| Target 13 Signals |
|
| Target 13 Transmembrane Regions |
|
| Target 13 Essentiality |
Essential |
| Target 13 GenBank ID Protein |
Not Available |
| Target 13 UniProtKB/Swiss-Prot ID |
Q9JMX9  |
| Target 13 UniProtKB/Swiss-Prot Entry Name |
Q9JMX9_HELPY  |
| Target 13 PDB ID |
1S2X  |
| Target 13 PDB File |
Show |
| Target 13 3D Structure |
|
| Target 13 Cellular Location |
Not Available |
| Target 13 Gene Sequence |
>600 bp
TTATTCCAAATTTAATTTTAATTGGGTTATCAATTTAGCTCTTTCTAAAGAAGTGAGATA
AGTCTTATTTTTGCTCAAAATAATATATTTAGTCCCTATATCTTGGACAATCTCATTGAG
CTTTTTCCCAAAATCATCTATCCCTAGAATCTGAAACGCCACGCCCATCATATTGCCATC
TATGAATGGCGGTAAATACTCTCTTGGCAGATAAGAAGCCACTAGGTCTGAAATTCTTGC
CACTTCATCACACGTAAAATTATTGAAGTTGTCAGAAATTTCTGCAACAAACTCTCCAAG
CGTTAGTTCATTTTTGATCGTGCTTTCTGCAAAAGTCTTTTCTTGTTTGCAACGATTGTA
ACTGGCTAACACAAGGTTGTTTAAATAGTTGTAATAAGCATCAAAACTAATAAAATTCTT
TTGCATATTGATTCTTAACTCTTGAACTCTTCTCAAAAAATCTTGTGGATCGTTGCTATC
TTTTAAAGAAGTGGCGTAATTTTGAATAAACTTATCCCTTACTTCATTCGCATTTCTCAT
AAGAGAACTGTTGCTATCTAAGATCTTTTGTCTTTCTGCTTCATTGAAACCGAGTTCCAT
|
| Target 13 GenBank Gene ID |
|
| Target 13 GeneCard ID |
Not Available |
| Target 13 GenAtlas ID |
Not Available |
| Target 13 HGNC ID |
Not Available |
| Target 13 Chromosome Location |
Not Available |
| Target 13 Locus |
Not Available |
| Target 13 SNPs |
SNPJam Report  |
| Target 13 General References |
- Covacci A, Rappuoli R: Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell. J Exp Med. 2000 Feb 21;191(4):587-92. [PubMed
]
- Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A: cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14648-53. [PubMed
]
|
| Target 13 Drug References |
Not Available |
|
Drug Target 14
[top]
|
| Target 14 ID |
5660 |
| Target 14 Name |
Esterase EstB |
| Target 14 Synonyms |
Not Available |
| Target 14 Gene Name |
estB |
| Target 14 Protein Sequence |
>Esterase EstB
MTAASLDPTAFSLDAASLAARLDAVFDQALRERRLVGAVAIVARHGEILYRRAQGLADRE
AGRPMREDTLFRLASVTKPIVALAVLRLVARGELALDAPVTRWLPEFRPRLADGSEPLVT
IHHLLTHTSGLGYWLLEGAGSVYDRLGISDGIDLRDFDLDENLRRLASAPLSFAPGSGWQ
YSLALDVLGAVVERATGQPLAAAVDALVAQPLGMRDCGFVSAEPERFAVPYHDGQPEPVR
MRDGIEVPLPEGHGAAVRFAPSRVFEPGAYPSGGAGMYGSADDVLRALEAIRANPGFLPE
TLADAARRDQAGVGAETRGPGWGFGYLSAVLDDPAAAGTPQHAGTLQWGGVYGHSWFVDR
ALGLSVLLLTNTAYEGMSGPLTIALRDAVYAR
|
| Target 14 Number of Residues |
398 |
| Target 14 Molecular Weight |
41708 |
| Target 14 Theoretical pI |
5.12 |
| Target 14 GO Classification |
|
Function
|
catalytic activity
hydrolase activity
hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds
hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides
beta-lactamase activity |
|
Process
|
physiological process
metabolism
cellular metabolism
drug metabolism
antibiotic metabolism
antibiotic catabolism
beta-lactam antibiotic catabolism
response to stimulus
response to abiotic stimulus
response to chemical stimulus
response to drug
response to antibiotic |
|
Component
|
| Not Available |
|
| Target 14 General Function |
Involved in beta-lactamase activity |
| Target 14 Specific Function |
Not Available |
| Target 14 Pathways |
Not Available
|
| Target 14 Reactions |
Not Available |
| Target 14 Pfam Domain Function |
|
| Target 14 Signals |
|
| Target 14 Transmembrane Regions |
|
| Target 14 Essentiality |
Essential |
| Target 14 GenBank ID Protein |
Not Available |
| Target 14 UniProtKB/Swiss-Prot ID |
Q9KX40  |
| Target 14 UniProtKB/Swiss-Prot Entry Name |
Q9KX40_9BURK  |
| Target 14 PDB ID |
1CI9  |
| Target 14 PDB File |
Show |
| Target 14 3D Structure |
|
| Target 14 Cellular Location |
|
| Target 14 Gene Sequence |
>1179 bp
TCAGCGCGCGTAGACGGCGTCGCGCAAGGCGATCGTCAGCGGGCCCGACATGCCTTCGTA
GGCGGTATTGGTGAGCAGCAGCACGCTGAGTCCCAGCGCGCGGTCGACGAACCAGGAATG
GCCATAGACGCCGCCCCATTGCAGCGTCCCGGCGTGCTGCGGGGTGCCGGCCGCGGCCGG
ATCGTCGAGCACCGCGCTCAGGTAGCCGAAGCCCCAGCCGGGGCCGCGCGTCTCGGCGCC
GACTCCGGCCTGGTCGCGGCGCGCCGCGTCGGCCAGCGTCTCGGGCAGGAAACCGGGATT
GGCGCGGATCGCCTCGAGCGCGCGCAGGACGTCGTCGGCCGAGCCGTACATGCCGGCGCC
GCCCGAGGGATAGGCGCCCGGCTCGAACACGCGGGAGGGCGCGAAACGCACGGCCGCGCC
GTGGCCTTCCGGCAGCGGCACCTCGATGCCGTCGCGCATGCGCACCGGCTCCGGCTGGCC
GTCGTGGTAAGGCACGGCGAAGCGCTCGGGCTCCGCCGAGACGAAACCGCAATCGCGCAT
GCCGAGCGGCTGGGCGACCAACGCGTCCACCGCCGCGGCCAGCGGCTGCCCGGTGGCGCG
CTCGACCACCGCGCCGAGCACGTCGAGCGCCAGCGAATACTGCCAGCCGCTGCCCGGCGC
GAAGGACAGCGGCGCCGAGGCGAGGCGGCGCAGGTTTTCGTCGAGATCGAAGTCGCGCAG
GTCGATGCCGTCCGAGATGCCGAGCCGGTCGTACACGGAGCCGGCGCCCTCGAGCAGCCA
GTAGCCGAGCCCCGACGTGTGCGTGAGCAGGTGGTGAATCGTGACGAGCGGCTCGCTGCC
GTCGGCCAGCCGCGGCCGGAATTCGGGCAACCAGCGCGTGACCGGCGCGTCGAGCGCGAG
TTCGCCGCGCGCCACCAGCCGCAGCACCGCCAGCGCGACGATCGGCTTGGTCACCGAAGC
GAGCCGGAACAGCGTGTCCTCGCGCATCGGCCGACCTGCCTCTCGGTCGGCCAGGCCCTG
GGCGCGGCGATACAGGATCTCGCCGTGCCGCGCGACGATCGCCACCGCGCCGACCAGGCG
CCGTTCGCGCAGCGCCTGGTCGAACACGGCATCGAGACGCGCGGCCAGCGAGGCGGCATC
GAGGGAGAAAGCGGTCGGGTCGAGCGAGGCAGCGGTCAT
|
| Target 14 GenBank Gene ID |
|
| Target 14 GeneCard ID |
Not Available |
| Target 14 GenAtlas ID |
Not Available |
| Target 14 HGNC ID |
Not Available |
| Target 14 Chromosome Location |
Not Available |
| Target 14 Locus |
Not Available |
| Target 14 SNPs |
SNPJam Report  |
| Target 14 General References |
- Petersen EI, Valinger G, Solkner B, Stubenrauch G, Schwab H: A novel esterase from Burkholderia gladioli which shows high deacetylation activity on cephalosporins is related to beta-lactamases and DD-peptidases. J Biotechnol. 2001 Jul 26;89(1):11-25. [PubMed
]
- Wagner UG, Petersen EI, Schwab H, Kratky C: EstB from Burkholderia gladioli: a novel esterase with a beta-lactamase fold reveals steric factors to discriminate between esterolytic and beta-lactam cleaving activity. Protein Sci. 2002 Mar;11(3):467-78. [PubMed
]
|
| Target 14 Drug References |
Not Available |
|
Drug Target 15
[top]
|
| Target 15 ID |
5661 |
| Target 15 Name |
Aeromonas caviae phaC PHA synthase,complete cds |
| Target 15 Synonyms |
Not Available |
| Target 15 Gene Name |
Not Available |
| Target 15 Protein Sequence |
>Aeromonas caviae phaC PHA synthase,complete cds
MSAQSLEVGQKARLSKRFGAAEVAAFAALSEDFNPLHLDPAFAATTAFERPIVHGMLLAS
LFSGLLGQQLPGKGSIYLGQSLSFKLPVFVGDEVTAEVEVTALREDKPIATLTTRIFTQG
GALAVTGEAVVKLP
|
| Target 15 Number of Residues |
136 |
| Target 15 Molecular Weight |
14086 |
| Target 15 Theoretical pI |
5.71 |
| Target 15 GO Classification |
|
Function
|
oxidoreductase activity
catalytic activity
transferase activity
transferase activity, transferring acyl groups
transferase activity, transferring groups other than amino-acyl groups
acyltransferase activity
fatty-acid synthase activity |
|
Process
|
physiological process
metabolism
cellular metabolism
organic acid metabolism
carboxylic acid metabolism
fatty acid metabolism
fatty acid biosynthesis |
|
Component
|
protein complex
fatty acid synthase complex |
|
| Target 15 General Function |
Involved in fatty-acid synthase activity |
| Target 15 Specific Function |
Not Available |
| Target 15 Pathways |
Not Available
|
| Target 15 Reactions |
Not Available |
| Target 15 Pfam Domain Function |
|
| Target 15 Signals |
|
| Target 15 Transmembrane Regions |
|
| Target 15 Essentiality |
Essential |
| Target 15 GenBank ID Protein |
Not Available |
| Target 15 UniProtKB/Swiss-Prot ID |
O32472  |
| Target 15 UniProtKB/Swiss-Prot Entry Name |
O32472_AERPU  |
| Target 15 PDB ID |
1IQ6  |
| Target 15 PDB File |
Show |
| Target 15 3D Structure |
|
| Target 15 Cellular Location |
Not Available |
| Target 15 Gene Sequence |
>405 bp
ATGAGCGCACAATCCCTGGAAGTAGGCCAGAAGGCCCGTCTCAGCAAGCGGTTCGGGGCG
GCGGAGGTAGCCGCCTTCGCCGCGCTCTCGGAGGACTTCAACCCCCTGCACCTGGACCCG
GCCTTCGCCGCCACCACGGCGTTCGAGCGGCCCATAGTCCACGGCATGCTGCTCGCCAGC
CTCTTCTCCGGGCTGCTGGGCCAGCAGTTGCCGGGCAAGGGGAGCATCTATCTGGGTCAA
AGCCTCAGCTTCAAGCTGCCGGTCTTTGTCGGGGACGAGGTGACGGCCGAGGTGGAGGTG
ACCGCCCTTCGCGAGGACAAGCCCATCGCCACCCTGACCACCCGCATCTTCACCCAAGGC
GGCGCCCTCGCCGTGACGGGGGAAGCCGTGGTCAAGCTGCCTTAA
|
| Target 15 GenBank Gene ID |
|
| Target 15 GeneCard ID |
Not Available |
| Target 15 GenAtlas ID |
Not Available |
| Target 15 HGNC ID |
Not Available |
| Target 15 Chromosome Location |
Not Available |
| Target 15 Locus |
Not Available |
| Target 15 SNPs |
Not Available |
| Target 15 General References |
- Fukui T, Doi Y: Cloning and analysis of the poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) biosynthesis genes of Aeromonas caviae. J Bacteriol. 1997 Aug;179(15):4821-30. [PubMed
]
|
| Target 15 Drug References |
Not Available |
|
Drug Target 16
[top]
|
| Target 16 ID |
5662 |
| Target 16 Name |
YojF protein |
| Target 16 Synonyms |
Not Available |
| Target 16 Gene Name |
yojF |
| Target 16 Protein Sequence |
>YojF protein
MKAIIKEDVQASLERYADRPVYIHLETTTGSYSAHLNEKNMTVVAYIRNAKVTYHQAKIK
GNGPYRVGLKTEEGWIYAEGLTEYTVDEENRLLMAGHLPGGKLAISLQISEKPFTV
|
| Target 16 Number of Residues |
117 |
| Target 16 Molecular Weight |
13042 |
| Target 16 Theoretical pI |
7.81 |
| Target 16 GO Classification |
Not Available |
| Target 16 General Function |
Not Available |
| Target 16 Specific Function |
Not Available |
| Target 16 Pathways |
Not Available
|
| Target 16 Reactions |
Not Available |
| Target 16 Pfam Domain Function |
Not Available |
| Target 16 Signals |
|
| Target 16 Transmembrane Regions |
|
| Target 16 Essentiality |
Essential |
| Target 16 GenBank ID Protein |
Not Available |
| Target 16 UniProtKB/Swiss-Prot ID |
O31858  |
| Target 16 UniProtKB/Swiss-Prot Entry Name |
O31858_BACSU  |
| Target 16 PDB ID |
1NJH  |
| Target 16 PDB File |
Show |
| Target 16 3D Structure |
|
| Target 16 Cellular Location |
Not Available |
| Target 16 Gene Sequence |
>351 bp
TTAAACTGTGAACGGTTTTTCGCTGATTTGCAGAGAAATAGCCAGTTTACCGCCCGGCAG
GTGTCCCGCCATTAATAAACGGTTTTCTTCATCTACCGTGTATTCAGTCAAGCCTTCAGC
ATAAATCCAGCCTTCTTCTGTTTTCAAGCCAACGCGGTAAGGCCCGTTGCCTTTGATTTT
TGCCTGATGATAAGTGACTTTTGCATTGCGAATATACGCAACAACCGTCATGTTCTTTTC
ATTTAAGTGCGCTGAATAAGAACCTGTGGTGGTTTCTAAATGGATATATACAGGGCGGTC
CGCATATCGTTCTAAAGATGCTTGCACATCTTCTTTTATGATCGCTTTCAT
|
| Target 16 GenBank Gene ID |
|
| Target 16 GeneCard ID |
Not Available |
| Target 16 GenAtlas ID |
Not Available |
| Target 16 HGNC ID |
Not Available |
| Target 16 Chromosome Location |
Not Available |
| Target 16 Locus |
Not Available |
| Target 16 SNPs |
SNPJam Report  |
| Target 16 General References |
- Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56. [PubMed
]
|
| Target 16 Drug References |
Not Available |
|
Drug Target 17
[top]
|
| Target 17 ID |
5663 |
| Target 17 Name |
Hypothetical protein |
| Target 17 Synonyms |
Not Available |
| Target 17 Gene Name |
Not Available |
| Target 17 Protein Sequence |
>Hypothetical protein
MTYVLYGIKACDTMKKARTWLDEHKVAYDFHDYKAVGIDREHLRRWCAEHGWQTVLNRAG
TTFRKLDEAQKADLDEAKAIELMLAQPSMIKRPVLELGGRTLVGFKPDAYAAALA
|
| Target 17 Number of Residues |
116 |
| Target 17 Molecular Weight |
13111 |
| Target 17 Theoretical pI |
8.69 |
| Target 17 GO Classification |
|
Function
|
catalytic activity
oxidoreductase activity |
|
Process
|
physiological process
metabolism
cellular metabolism
generation of precursor metabolites and energy
electron transport |
|
Component
|
| Not Available |
|
| Target 17 General Function |
Involved in oxidoreductase activity |
| Target 17 Specific Function |
Not Available |
| Target 17 Pathways |
Not Available
|
| Target 17 Reactions |
Not Available |
| Target 17 Pfam Domain Function |
|
| Target 17 Signals |
|
| Target 17 Transmembrane Regions |
|
| Target 17 Essentiality |
Essential |
| Target 17 GenBank ID Protein |
Not Available |
| Target 17 UniProtKB/Swiss-Prot ID |
Q9HXX5  |
| Target 17 UniProtKB/Swiss-Prot Entry Name |
Q9HXX5_PSEAE  |
| Target 17 PDB ID |
1RW1  |
| Target 17 PDB File |
Show |
| Target 17 3D Structure |
|
| Target 17 Cellular Location |
Not Available |
| Target 17 Gene Sequence |
>348 bp
ATGACCTACGTTCTCTACGGCATCAAAGCCTGCGACACCATGAAGAAGGCTCGGACCTGG
CTCGACGAGCACAAGGTCGCCTACGACTTCCACGACTACAAGGCCGTCGGCATCGACCGC
GAACACCTGCGGCGCTGGTGCGCGGAGCACGGCTGGCAAACCGTCCTCAACCGCGCCGGC
ACCACCTTCCGCAAGCTCGACGAAGCGCAGAAGGCCGATCTCGACGAAGCCAAGGCGATC
GAGCTGATGCTGGCCCAGCCGTCGATGATCAAGCGCCCGGTGCTGGAGCTGGGCGGCAGG
ACGCTGGTCGGCTTCAAGCCCGACGCCTACGCCGCCGCCCTGGCCTGA
|
| Target 17 GenBank Gene ID |
|
| Target 17 GeneCard ID |
Not Available |
| Target 17 GenAtlas ID |
Not Available |
| Target 17 HGNC ID |
Not Available |
| Target 17 Chromosome Location |
Not Available |
| Target 17 Locus |
Not Available |
| Target 17 SNPs |
Not Available |
| Target 17 General References |
- Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64. [PubMed
]
|
| Target 17 Drug References |
Not Available |
|
Drug Target 18
[top]
|
| Target 18 ID |
5664 |
| Target 18 Name |
Phospholipase A2-3 |
| Target 18 Synonyms |
- EC 3.1.1.4
- MP-III 4R
- Phosphatidylcholine 2-acylhydrolase
- Piratoxin-III
- PrTX-III
|
| Target 18 Gene Name |
Not Available |
| Target 18 Protein Sequence |
>Phospholipase A2-3
DLWQFGQMILKETGKLPFPYYTYGGCYCGVGGRRGLGTKDDRCCYVHDCCYKKLTGCPKT
DDRYSYSWLDLTIVCGEDDPCKELCECDKAIAVCFRENLGTYNKKYRYHLKPCKKADKPC
|
| Target 18 Number of Residues |
122 |
| Target 18 Molecular Weight |
13834 |
| Target 18 Theoretical pI |
8.06 |
| Target 18 GO Classification |
|
Function
|
binding
ion binding
cation binding
calcium ion binding
catalytic activity
hydrolase activity
hydrolase activity, acting on ester bonds
carboxylic ester hydrolase activity
lipase activity
phospholipase activity
phospholipase A2 activity |
|
Process
|
physiological process
metabolism
primary metabolism
lipid metabolism
lipid catabolism |
|
Component
|
| Not Available |
|
| Target 18 General Function |
Involved in phospholipase A2 activity |
| Target 18 Specific Function |
PA2 catalyzes the calcium-dependent hydrolysis of the 2- acyl groups in 3-sn-phosphoglycerides. Has moderate PLA2 activity but a strong myotoxic activity. Also has anticoagulant activity |
| Target 18 Pathways |
Not Available
|
| Target 18 Reactions |
Not Available |
| Target 18 Pfam Domain Function |
|
| Target 18 Signals |
|
| Target 18 Transmembrane Regions |
|
| Target 18 Essentiality |
Essential |
| Target 18 GenBank ID Protein |
Not Available |
| Target 18 UniProtKB/Swiss-Prot ID |
P58464  |
| Target 18 UniProtKB/Swiss-Prot Entry Name |
PA23_BOTPI  |
| Target 18 PDB ID |
Not Available |
| Target 18 Cellular Location |
|
| Target 18 Gene Sequence |
Not Available |
| Target 18 GenBank Gene ID |
|
| Target 18 GeneCard ID |
Not Available |
| Target 18 GenAtlas ID |
Not Available |
| Target 18 HGNC ID |
Not Available |
| Target 18 Chromosome Location |
Not Available |
| Target 18 Locus |
Not Available |
| Target 18 SNPs |
Not Available |
| Target 18 General References |
- Toyama MH, Costa PD, Novello JC, de Oliveira B, Giglio JR, da Cruz-Hofling MA, Marangoni S: Purification and amino acid sequence of MP-III 4R D49 phospholipase A2 from Bothrops pirajai snake venom, a toxin with moderate PLA2 and anticoagulant activities and high myotoxic activity. J Protein Chem. 1999 Apr;18(3):371-8. [PubMed
]
|
| Target 18 Drug References |
Not Available |
|
Drug Target 19
[top]
|
| Target 19 ID |
5665 |
| Target 19 Name |
Trp operon repressor |
| Target 19 Synonyms |
Not Available |
| Target 19 Gene Name |
trpR |
| Target 19 Protein Sequence |
>Trp operon repressor
MAQQSPYSAAMAEQRHQEWLRFVDLLKNAYQNDLHLPLLNLMLTPDEREALGTRVRIVEE
LLRGEMSQRELKNELGAGIATITRGSNSLKAAPVELRQWLEEVLLKSD
|
| Target 19 Number of Residues |
109 |
| Target 19 Molecular Weight |
12355 |
| Target 19 Theoretical pI |
5.20 |
| Target 19 GO Classification |
|
Function
|
binding
nucleic acid binding
DNA binding
transcription factor activity |
|
Process
|
regulation of biological process
regulation of physiological process
regulation of metabolism
regulation of cellular metabolism
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolism
regulation of transcription
regulation of transcription, DNA-dependent |
|
Component
|
cell
intracellular |
|
| Target 19 General Function |
Involved in transcription factor activity |
| Target 19 Specific Function |
This protein is an aporepressor. When complexed with L- tryptophan it binds the operator region of the trp operon (5'- ACTAGT-'3') and prevents the initiation of transcription. The complex also regulates trp repressor biosynthesis by binding to its regulatory region (By similarity) |
| Target 19 Pathways |
Not Available
|
| Target 19 Reactions |
Not Available |
| Target 19 Pfam Domain Function |
|
| Target 19 Signals |
|
| Target 19 Transmembrane Regions |
|
| Target 19 Essentiality |
Essential |
| Target 19 GenBank ID Protein |
Not Available |
| Target 19 UniProtKB/Swiss-Prot ID |
P0A883  |
| Target 19 UniProtKB/Swiss-Prot Entry Name |
TRPR_SHIFL  |
| Target 19 PDB ID |
3WRP  |
| Target 19 PDB File |
Show |
| Target 19 3D Structure |
|
| Target 19 Cellular Location |
- Cytoplasm (By similarity)
|
| Target 19 Gene Sequence |
>327 bp
ATGGCCCAACAATCACCCTATTCAGCAGCGATGGCAGAACAGCGTCACCAGGAGTGGTTA
CGTTTTGTCGACCTGCTTAAGAATGCCTACCAAAACGATCTCCATTTACCGTTGTTAAAC
CTGATGCTGACGCCAGATGAGCGCGAAGCGTTGGGGACTCGCGTGCGTATTGTCGAAGAG
CTGTTGCGTGGCGAAATGAGTCAGCGTGAGTTAAAAAATGAACTCGGCGCGGGCATCGCG
ACGATTACGCGTGGATCTAACAGCCTGAAAGCCGCGCCCGTGGAGCTGCGTCAGTGGCTG
GAAGAGGTGTTGCTGAAAAGCGATTGA
|
| Target 19 GenBank Gene ID |
|
| Target 19 GeneCard ID |
Not Available |
| Target 19 GenAtlas ID |
Not Available |
| Target 19 HGNC ID |
Not Available |
| Target 19 Chromosome Location |
Not Available |
| Target 19 Locus |
Not Available |
| Target 19 SNPs |
SNPJam Report  |
| Target 19 General References |
- Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41. [PubMed
]
- Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86. [PubMed
]
|
| Target 19 Drug References |
Not Available |